Egs2022 Prog 0606

15th EGS Congress
Scientific Programme
Athens | 4-8 June 2022
www.eugs.org
group
2
15th EGS Congress | Athens | 4-8 June 2022
The EGS Surgery Day
Saturday, 4 June 2022

“Excellence is never an accident” - Aristotle
07:00 Registration
09:00

09:00 Welcome and introduction
09:05 Fotis Topouzis (Greece) Socrates
Session A - Glaucoma surgery: evidence versus influence?

09:05
10:09 Moderators: Luis Abegão Pinto (Portugal) Socrates
Ingeborg Stalmans (Belgium)
Keith Barton
Oracle versus science (United Kingdom)
Norbert Pfeiffer
To MIGS or not to MIGS? (Germany)
“I am easy to please, just give me the best”: personalized medicine in Gordana Sunaric Mégevand
surgery (Switzerland)
David Garway-Heath
Which outcomes matter? (United Kingdom)
Discussion
Session B - Pathways to success

10:10
11:15 Moderators: Marta Pazos (Spain) Socrates
Carlo E. Traverso (Italy)
Ernst Tamm
The labyrinth of physiological outflow (Germany)
Ingeborg Stalmans
Dealing with healing (Belgium)
Julian Garcia-Feijoo
Don’t forget Poiseuille’s law (Spain)
Richard Lee
Material differences, do they matter? (United Kingdom)
Discussion
3
Parallel Hot spots
11:20 Moderators: James Kirwan (United Kingdom)

11:41 Socrates Foyer
Alain Bron (France)
Julian Garcia Feijoo (Spain)
11:20 Station 1
Eleni Nikita
My way to perform releasable sutures (United Kingdom)
Barbara Cvenkel
SLT: when and how? (Slovenia)
11:20 Station 2
Philip Bloom
My way to endoscopic cyclodestruction (United Kingdom)
Efthymios Karmiris
Surgery after corneal grafts (Greece)
11:20 Station 3
Andreas Katsanos
Neovascular glaucoma: what is the best surgical option? (Greece)
Vassilios Kozobolis
Glaucoma surgeries in complex dysgenetic cases (Greece)
Session C - EGS and Surgical Innovations

11:45
12:55 Moderators: Manuele Michelessi (Italy) Socrates
Fotis Topouzis (Greece)
Jane Blazeby
Keynote lecture - Evidence based surgical innovation (United Kingdom)
Augusto Azuara-Blanco
EGS Guidelines on surgical innovations (United Kingdom)
Luis Abegão Pinto
Recommendations for everyday surgery: do’s and don’ts (Portugal)
Anthony King
A rational approach to surgical complications (United Kingdom)
Discussion

not EACCME accredited
13:00 Parallel Industry Sessions

14:00 (see page 49-50) Parallel Rooms
4
Session D - State of the art and results of various

14:00 surgeries
15:15 Moderators: A Socrates
ntonio Fea (Italy)
Andrew McNaught (United Kingdom)
James Kirwan
Trabeculectomy (United Kingdom)
Susana Duch
Tubes (Spain)
Nitin Anand
Non penetrating surgery (United Kingdom)
Jose Maria Martinez de la
MIGS Casa (Spain)
Karl Mercieca
Bleb forming devices (Germany)
Discussion
Session E - Debate and Q&A (with voting)

15:20
16:15 Moderators: Keith Barton (United Kingdom) Socrates
Julian Garcia-Feijoo (Spain)
Is surgery the way to go in early disease?
Theodoros Filippopoulos
- Yes: (Greece)
15:23
- No: Jörg Stürmer
(Switzerland)
Is trabeculectomy the best treatment in advanced cases?
Andrew McNaught
- Yes: (United Kingdom)
15:40
- No: Verena Prokosch
(Germany)
Significant cataract and advanced glaucoma: combined or sequential?
Clemens Vass
- Sequential: (Austria)
15:57
- Combined: Stefano Gandolfi
(Italy)
5
Parallel Hot spots
16:25 Moderators: Andrew McNaught (United Kingdom)

16:46 Socrates Foyer
Clemens Vass (Austria)
Jörg Stürmer (Switzerland)
16:25 Station 1
Siri Mohammed Ezzouhairi

Surgery in uveitic glaucoma
(Morocco)
Esther Hoffmann
Surgery in congenital glaucoma (Germany)
16:25 Station 2
Yves Lachkar
Surgery in high myopia (France)
Alain Bron
Surgery in nanophthalmos (France)

16:25 Station 3
Stefano Miglior
Choosing IOL for glaucoma patients (Italy)
Dimitris Mikropoulos
Managing a subluxated IOL in PEX glaucoma (Greece)

Session F - Video session (with voting)
16:55
18:30 Moderators: Stefano Gandolfi (Italy) Socrates
Jose Maria Martinez de la Casa (Spain)
Carlo E. Traverso
A dysmorphic bleb (Italy)
Thomas Klink
Buttonholes and other complications (Germany)
Giorgio Marchini
My needlings and revisions (Italy)
Herbert Reitsamer
Surgery in bad conjunctivas (failed previous surgeries) (Austria)
Andrew McNaught
Overfiltering bleb (United Kingdom)
Andrew Tatham
Combined procedure (United Kingdom)
Discussion

18:30 Summary and end of the Surgery Day
Gordana Sunaric Mégevand (Switzerland), Luis Abegão Pinto (Portugal)
6
EGS Main Congress

“Wonder is the beginning of wisdom” - Socrates
07:00 Registration
09:00
09:00
09:35 Opening Session Plenary Room
Sunday, 5 June 2022

Fotis Topouzis
09:00 Welcome by the president (Greece)
09:25 New EGS projects
09:25 The future of EGS: NGP and FEBOS Ingeborg Stalmans

09:35 (Belgium)
09:35 Gauti Jóhannesson

09:45 EGS Showcase (Sweden)
09:45
10:15 The Jules François lecture Plenary Room
Fotis Topouzis
Introduction (Greece)
The value and need for continuous monitoring of real-world data and Anja Tuulonen
outcomes in glaucoma care (Finland)
Coffee break and Poster Session 1 (see page 27)

10:15 Moderators: Carlo Alberto Cutolo (Italy)
10:45 Poster Area
Sophie Lemmens (Belgium)
Eleni Nikita (United Kingdom)
7
Session 1 - Back to basics: what’s new?
10:45
11:35 Moderators: Franz Grehn (Germany) Plenary Room
Norbert Pfeiffer (Germany)
Leonard Levin
What is the Big Bang for glaucomatous neuropathy? (Canada)
Felipe Medeiros
Why do we still measure IOP? (USA)
Michael Girard
The biomechanics of the optic nerve head (Singapore)
Sunday, 5 June 2022
Discussion
Session 2 - Take the pulse on…

11:40
12:45 Moderators: Gerhard Garhöfer (Austria) Plenary Room
Anthony Khawaja (United Kingdom)
Stefano Miglior
OHT / glaucoma suspects: too much or not enough? (Italy)
Deborah Kamal
Normal tension glaucoma: challenges in diagnosis and management (United Kingdom)
Panayiota Founti
Exfoliation: what is so special about it? (United Kingdom)
Winifred Nolan
Angle closure: when to do an iridotomy? (United Kingdom)
Discussion

12:50 Educational Partner Symposium
14:20 (see page 51) Plenary Room

Session 3 - Can glaucoma be reversed?

14:25
15:45 Moderators: Gauti Johannesson (Sweden) Plenary Room
Leonard Levin (Canada)
Leonard Levin
Introduction (Canada)
Jonathan Crowston
Why have trials failed so far to prove effectiveness? (United Kingdom)
David Garway-Heath
Glaucoma pathophysiology: latest discoveries (United Kingdom)
Jeffrey Liebmann
Can glaucoma be reversed with nicotinamide? Trials and limitations (USA)
Luca Rossetti
Can glaucoma be reversed with citicoline? Trials and limitations (Italy)
Can glaucoma be reversed with neuroregeneration? Prospects and Keith Martin
limitations (Australia)
Discussion
8
15:45
16:45 National Societies Meetings
Greek Glaucoma Society (GGS) / Associazione Italiana

per lo Studio del Glaucoma (AISG)
15:45
16:45 New frontiers in Glaucoma Diagnosis and Treatment Plenary Room
Sunday, 5 June 2022

Moderators: Georgios Magkouritsas (Greece)
Stefano Miglior (Italy)
Glaucoma diagnosis: the use of both surgical and functional metrics Andreas Katsanos
makes the difference in glaucoma diagnosis (Greece)
Ioannis Halkiadakis
Glaucoma imaging: OCT angiography makes the difference (Greece)
Luca Rossetti
Glaucoma treatment: neuroprotection makes the difference (Italy)
Antonio Maria Fea
Glaucoma surgery: MIGS makes the difference (Italy)
Discussion
Alpine Group - Austrian, Swiss and German

National Societies Symposium
15:45
16:45 Moderators: Esther Hoffmann (Germany) Skalkotas
Anton Hommer (Austria)
Frances Meier-Gibbons (Switzerland)
Markus Lenzhofer
Overview of endothelial cell count loss after glaucoma surgeries (Austria)
Neurofilament Light Chain - a new marker for neuronal decay in the Ewald Lindner
aqueous humor of glaucoma patients (Austria)
Julia Stingl
Trabeculectomy versus modified canaloplasty: tips and tricks (Germany)
Stephanie Joachim
Immune-mediated cell death mechanisms in glaucoma (Germany)
Jörg Stürmer
A case of probably iatrogenic angle-closure (Switzerland)
Christoph Kniestedt
Correlation between IOP and yoga position (Switzerland)
9
World Glaucoma Association (WGA)
15:45 Glaucoma and non-IOP related risk factors
16:45 Moderators: Ingrida Januleviciene (Lithuania) Socrates
Zeynep Kayaarasi Ozturker (Turkey)
Luciano Quaranta
Blood pressure and progression of glaucoma (Italy)
Using artificial intelligence to detect non-IOP related risk factors in Alon Harris
glaucoma (USA)
Miriam Kolko
Oxidative stress and inflammation in glaucoma (Denmark)
Sunday, 5 June 2022
Shan Lin
Neurorecovery in glaucoma - myths and reality (USA)
Discussion
Société Française du Glaucome (SFG)

15:45 The new micro-invasive glaucoma surgical techniques
16:45 Moderators: Florent Aptel (France) Hippocrates 1
Antoine Labbé (France)
Cédric Schweitzer
With subconjunctival filtration ab interno (France)
Florent Aptel
With subconjunctival filtration ab externo
(France)
Antoine Labbé
With trabecular bypass
(France)
Muriel Poli
With suprachoroidal outflow
(France)
Discussion
Asian Pacific Glaucoma Society (APGS)

Advancing clinical glaucoma care through outstanding
15:45
16:45 research Hippocrates 2
Moderators: Tin Aung (Singapore)
Prin Rojanapongpun (Thailand)
Geometric Deep Learning in Glaucoma - A new approach to exploit Michael Girard
complex 3D structural data (Singapore)
Management of asymptomatic narrow angles (PACS): lessons from Tin Aung
recent trialsX (Singapore)
Leopold Schmetterer
OCT angiography in glaucoma (Singapore)
Prin Rojanapongpun
The biomechanics of filtering surgery (Thailand)
Discussion
10
Middle East Africa Glaucoma Society (MEAGS)

Impact of the Landmark Glaucoma Trials on the Daily
15:45
16:45 Glaucoma Practice Hippocrates 3
Moderators: Amel Meddeb-Ouertani (Tunisia)
Zeynep Aktas (Turkey)
Zeinab Elsanabary
Diagnosis and staging (Egypt)
Sidi Mohammed Ezzouhairi
Management of recently diagnosed POAG (Morocco)
Sunday, 5 June 2022

Ali Alsheikheh
Advanced open angle glaucoma (Oman)
Ahmed Abdelrahman
Glaucoma in a pseudophakic eye (Egypt)
Discussion
Turkish Ophthalmological Association (TOS) - Glaucoma

Section
15:45
16:45 New Concepts in Glaucoma Hippocrates 4
Moderators: Ilgaz Yalvac (Turkey)
Kivanc Gungor (Turkey)
The lymphatics, waste clearance in the eye and implications for Keith Barton
glaucoma (United Kingdom)
David Garway-Heath
Predicting the visual field from OCT using AI (United Kingdom)
Ahmet Akman
Pearls and artifacts in Zeiss Cirrus HD OCT (Turkey)
Atilla Bayer
Pearls and artifacts in Heidelberg Spectralis OCT (Turkey)
Discussion
11
C1.03 - Instructional Course
The importance of the anterior chamber angle: why to
16:50 look there? How to exam? What to find?
17:50
Course Director: Anton Hommer (Austria) Plenary Room
rin Rojanapongpun (Thailand)
Course Co-Director: P
Speakers: Anton Hommer (Austria)
Prin Rojanapongpun (Thailand)
Sunday, 5 June 2022

Practical OCT examination in glaucoma
16:50 Course Director: B
alwantray Chauhan (Canada)
17:50
Course Co-Director: F rancisco Javier Goñi (Spain) Skalkotas
Speakers: Claude Burgoyne (USA)
Balwantray Chauhan (Canada)
Francisco Javier Goñi (Spain)

Phacoemulsification in glaucoma
16:50 Course Director: C arlo E. Traverso (Italy)
17:50
Course Co-Director: S tefano Miglior (Italy)
Socrates
Speakers: Stefano Miglior (Italy)

Trabeculectomy needling and revision
16:50 Course Director: A
ndrew Tatham (United Kingdom)
17:50
Course Co-Director: James Kirwan (United Kingdom) Hippocrates 1
Speakers: Keith Barton (United Kingdom)
Andrew Tatham (United Kingdom)

16:50 How to use the landmark trials in your clinic?
anayiota Founti (United Kingdom)
17:50 Course Director: P
Course Co-Director: E leni Nikita (United Kingdom)
Hippocrates 2
Speakers: Panayiota Founti (United Kingdom)
Eleni Nikita (United Kingdom)
12

Critical appraisal of MIGS evidence and methods for
16:50 introducing new surgical procedures
17:50
Course Director: Jane M. Blazeby (United Kingdom) Hippocrates 3
Course Co-Director: M anuele Michelessi (Italy)
Speakers: Jane M. Blazeby (United Kingdom)
Manuele Michelessi (Italy)
Sunday, 5 June 2022

16:50 Glaucoma medication - Today and tomorrow
erhard Garhöfer (Austria)
17:50 Course Director: G
auti Jóhannesson (Sweden)
Course Co-Director: G
Hippocrates 4
Speakers: Cornelia Hirn (Austria)
Francesco Oddone (Italy)

18:55 (see pages 51 - 52) Parallel Rooms
19:00 Welcome Reception

20:00
13
“The secret of change is to focus all of your energy, not on fighting the old,
but on building the new” - Socrates
08:00
08:50 EGS General Assembly Plenary Room
Session 4 - Precision medicine: going beyond the

09:00 classical “signs-and-symptoms”
10:40 Moderators: Hans Lemij (The Netherlands) Plenary Room
Fotis Topouzis
Why we need to move away from “one-size-fits-all” management? (Greece)
Ananth Viswanathan
Will genotyping change our everyday practice in the future? (United Kingdom)
Anne Coleman
Together we can! Big data & Real World Data (USA)
Monday, 6 June 2022
Stefan Klein
Will AI revolutionise glaucoma care? (The Netherlands)
Anthony Khawaja
Where do other biomarkers fit into this? (United Kingdom)
Alain Bron
Does lifestyle matter? (France)
Discussion

10:40 Moderators: Hana Abouzeid (Switzerland)
11:10 Poster Area
Eleftherios Anastasopoulos (Greece)
Muriel Poli (France)
14
Session 5 - Choosing wisely - improving our everyday

11:10 management
12:20 Moderators: Francisco Goñi (Spain) Plenary Room
Pradeep Ramulu
What VF damage matters to the patient? (USA)
Francesco Oddone
Who needs aggressive care? (Italy)
Stylianos Kandarakis
Timing of surgery: avoid fiddling while Rome burns (Greece)
Hans Lemij
Escaping the labyrinth: when to stop monitoring? (The Netherlands)
Discussion
12:20
Monday, 6 June 2022

12:30 EGS Showcase Plenary Room
Interview with
Special focus on the do’s and don’ts in the EGS Guidelines Michele Iester
(Italy)


14:15 SLT: why, when, how and for whom
15:15 Course Director: S tefano Gandolfi (Italy)
Course Co-Director: Gus Gazzard (United Kingdom)
Plenary Room
Speakers: Stefano Gandolfi (Italy)
Gus Gazzard (United Kingdom)

Prepare yourself for neuroprotection
14:15 Course Director: Keith Martin (Australia)
15:15
Course Co-Director: Jeffrey Liebmann (USA)
Skalkotas
Speakers: Jonathan Crowston (Singapore)
15
14:15 Managing complications at the slit lamp
15:15 Course Director: Carlo E. Traverso (Italy)
Socrates
Course Co-Director: Thomas Klink (Germany)
Speakers: Thomas Klink (Germany)

Evidence-based clinical guidelines: why and how?
ugusto Azuara-Blanco (United Kingdom)
15:15
Course Co-Director: Anja Tuulonen (Finland) Hippocrates 1
Speakers: Augusto Azuara-Blanco (United Kingdom)
Marta Pazos (Spain)
Anja Tuulonen (Finland)
Monday, 6 June 2022

Surgical approaches in mild-to-moderate glaucoma
patients: when, why and for whom
ntonio Maria Fea (Italy)
15:15
Course Co-Director: Jose Maria Martinez de la Casa (Spain) Hippocrates 2
Speakers: Antonio Maria Fea (Italy)
Jose Maria Martinez de la Casa (Spain)
Konrad Schargel (Spain)
Cédric Schweitzer (France)

Exfoliation glaucoma: an update on presentation and
14:15 management
abor Hóllo (Hungary)
Course Co-Director: Anastasios Konstas (Greece)
Hippocrates 3
Speakers: Tin Aung (Singapore)
Andreas Katsanos (Greece)
Vassilios Kozobolis (Greece)

Sparing the ocular surface in glaucoma
14:15 Course Director: C hristophe Baudouin (France)
15:15
Course Co-Director: Miriam Kolko (Denmark) Hippocrates 4
Speakers: Christophe Baudouin (France)
Alon Harris (USA)
Frances Meier-Gibbons (Switzerland)
16

15:30 NTG in clinical practice
16:30 Course Director: S elim Orgül (Switzerland)
Course Co-Director: Frances Meier Gibbons (Switzerland) Plenary Room
Speakers: Deborah Kamal (United Kingdom)
Frances Meier Gibbons (Switzerland)
Selim Orgül (Switzerland)

15:30 Treatment dilemmas in glaucoma
16:30 enny Beckers (The Netherlands)
Course Director: H
Course Co-Director: Andrew Scott (United Kingdom) Skalkotas
Speakers: Ronald de Crom (The Netherlands)
Andrew Scott (United Kingdom)
Monday, 6 June 2022

15:30 Detecting progression with structure and function
16:30 avid Garway-Heath (United Kingdom)
Course Director: D
Course Co-Director: Felipe Medeiros (USA)
Socrates
Speakers: David Garway-Heath (United Kingdom)
Felipe Medeiros (USA)

15:30 OCT - Sclera and optic disc mechanics
16:30 Course Director: C laude Burgoyne (USA)
Course Co-Director: Michael Girard (Singapore)
Hippocrates 1
Speakers: Claude Burgoyne (USA)
Michael Girard (Singapore)

15:30 What can we expect from Artificial Intelligence in
16:30 glaucoma management
ans Lemij (The Netherlands)
Course Director: H Hippocrates 2
Course Co-Director: Leopold Schmetterer (Singapore)
Speakers: Hans Lemij (The Netherlands)
Leopold Schmetterer (Singapore)
17
15:30 The use of Artificial Inteligence, transfer learning and
16:30 math models in the management of glaucoma
lon Harris (USA)
Course Director: A Hippocrates 3
Course Co-Director: Marta Pazos (Spain)
Speakers: Stefan Klein (The Netherlands)
Ananth Viswanathan (United Kingdom)

15:30 My worst surgical cases
16:30 Course Director: K
eith Barton (United Kingdom)
Course Co-Director: Ingeborg Stalmans (Belgium)
Hippocrates 4
Monday, 6 June 2022


19:15 (see page 54) Parallel Rooms
18
“Quality is not an act, it is a habit” - Aristotle
08:00 Industry Breakfast Session

08:45 (see page 55) Parallel Rooms
Session 6 - Vote for the Winner: Interactive session

09:00
10:30 Moderators: Francesco Oddone (Italy) Plenary Room
09:00 Tonometry: Goldmann for the old man?

- Yes: Arthur Sit
(USA)
- No: Anton Hommer
(Austria)
09:14 Q/A
09:20 Preservative-free for ALL?

- Yes: Anastasios Konstas
(Greece)
- No: Sheng Lim
(United Kingdom)
09:34 Q/A
09:40 SLT always first?

- Yes: Gus Gazzard
Tuesday, 7 June 2022

(United Kingdom)
- No: Cédric Schweitzer
(France)
09:54 Q/A
10:00 Blood flow and blood pressure: are they essential contributors to GON?
- Yes: Leopold Schmetterer
(Singapore)
- No: Jeffrey Liebmann
(USA)
10:14 Q/A
10:20 Gonioscopy or AS-OCT to interpret the angle?

- Gonioscopy is best: David Friedman
(USA)
- AS-OCT is best: Tin Aung
(Singapore)
10:34 Q/A
19
10:40 Moderators: Mario Economou (Switzerland)
11:00 Poster Area
Stylianos Georgoulas (United Kingdom)
Rapid Fires 1
10:40
11:00 Moderators: João Barbosa Breda (Portugal), Cornelia Hirn (Austria) Booth 1, 2, 3
Markus Karlsson (Sweden)
Booth 1
Comparison of machine learning approaches for focal visual field modelling
Damon Wong1,2, Jacqueline Chua1, Inna Bujor3, Alina Popa-Cherecheanu3,4, Leopold
Schmetterer1,2,5 (1Singapore, 2Switzerland, 3Romania, 4Romania, 5Austria)
The discriminative ability of two glaucoma diagnostic calculators in glaucoma suspects and glaucoma patients
Nestor Ventura Abreu, Marc Biarnés, Sofía Batlle, Maria Teresa Carrión Donderis, Rafael Castro
Domínguez, Javier Moreno Montañes, Marta Pazos (Spain)
Booth 2
Changing prevalence of glaucoma-related vision loss in Europe over the last 20 years: findings from
the Global Vision Database of the Vision Loss Expert Group
Rupert Bourne1, Jost Jonas2, Alain Bron3, Jaimie Steinmetz4, Paul Briant4, Tabassom Sedighi1,
Nicolas Leveziel3, Maria Cicinelli5, Luca Rossetti5, Ian Tapply1, Serge Resnikoff6, Theo Vos4, Hugh
Taylor6 (1United Kingdom, 2Germany, 3France, 4USA, 5Italy, 6Australia)
Glaucoma conversion of the contralateral eye in unilateral normal-tension glaucoma patients: a 5-year
follow-up study
Jin-Soo Kim, Hyuk Jin Choi, Ki Ho Park (South Korea)
Booth 3
Intraocular pressure fluctuation and rates of visual field progression in primary open-angle glaucoma:
an exploratory analysis from the United Kingdom Glaucoma Treatment Study (UKGTS)
Alessandro Rabiolo, Giovanni Montesano, David Crabb, David Garway-Heath (United Kingdom)
A simple surgical solution for the treatment of persistent postoperative hypotony after PreserFlo
MicroShunt implantation
Soledad Aguilar Munoa, Yih-Horng Tham, Keith Barton (United Kingdom)
Plenary Room
11:00 Gauti Jóhannesson
11:15 EGS Showcase (Sweden)
Session 7 - Diagnostic challenges

11:15
12:30 Moderators: David Garway-Heath (United Kingdom) Plenary Room
Marta Pazos (Spain)
Rupert Bourne
How to use your resources in a sustainable way? (United Kingdom)
Giovanni Montesano
The role of macular testing in diagnosing glaucoma (United Kingdom)
Claude Burgoyne
New structural parameters to distinguish myopic changes from glaucoma (USA)
Balwantray Chauhan
How useful is OCT-A for the diagnosis of glaucoma? (Canada)
Discussion

20

Session 8 - Tips and tricks: practical considerations in

14:05 glaucoma management
15:40 Moderators: Andrew McNaught (United Kingdom) Plenary Room
Frances Meier Gibbons (Switzerland)
Francisco Goñi
How many VF to diagnose and manage glaucoma? (Spain)
Eleftherios Anastasopoulos
The harm of over-diagnosing and over-treating (Greece)
Marta Pazos
Managing glaucoma and concomitant co-morbidities (Spain)
Alexandros Stangos
Curing the macula but killing the nerve? (Switzerland)
Discussion
Latest developments in medical and surgical therapy
Gerhard Garhöfer
New medications in the pipeline (Austria)
Antonio Fea
New surgeries in the pipeline (Italy)
Discussion
The EGS Patient project: communication with the patient

Moderators: Carol Bronze (United Kingdom),
15:45 Stylianos Georgoulas (United Kingdom)
16:45 Speakers: David Garway-Heath (United Kingdom) Plenary Room
Louise Evans (United Kingdom)
Stylianos Georgoulas (United Kingdom))

Is non-penetrating surgery still worth learning?
ordana Sunaric Mégevand (Switzerland)
16:45 Course Co-Director: Karl Mercieca (Germany)
Speakers: Nitin Anand (United Kingdom)
Skalkotas
Alessandro Rabiolo (United Kingdom)
Karl Mercieca (Germany)
Gordana Sunaric Mégevand (Switzerland)

15:45 If not glaucoma, what else? Differential diagnosis
16:45 Course Director: Leonard Levin (Canada)
Course Co-Director: Delphine Bifrare (Switzerland)
Socrates
Speakers: Delphine Bifrare (Switzerland)
21
All you need to know on glaucoma and genetics
15:45 Course Director: Fotis Topouzis (Greece)
16:45
Course Co-Director: Anthony Khawaja (United Kingdom) Hippocrates 1
Speakers: Tin Aung (Singapore)

Investigating Schlemm’s canal - Is this the way to go in
15:45 glaucoma?
16:45 Course Director: Ernst Tamm (Germany)
Course Co-Director: Sheng Lim (United Kingdom)
Hippocrates 2
Speakers: Franz Grehn (Germany)
Sheng Lim (United Kingdom)
Ernst Tamm (Germany)

15:45 Tube surgery
16:45 Course Director: Susana Duch (Spain)
Course Co-Director: Luis Abegão Pinto (Portugal) Hippocrates 3
Speakers: Luis Abegão Pinto (Portugal)
Carlos A. Arciniegas-Perasso (Spain)
Susana Duch (Spain)

15:45 Visual field examples - Artefacts, tricky cases
16:45 Course Director: H
ans Lemij (The Netherlands)
Course Co-Director: Barbara Cvenkel (Slovenia)
Hippocrates 4
Speakers: Barbara Cvenkel (Slovenia)
Hans Lemij (The Netherlands)

Congenital glaucoma
15:45 Course Director: Esther Hoffmann (Germany)
16:45 Course Co-Director: Alana Grajewski (USA)
Speakers: Elena Bitrian (USA)
Hippocrates 5
Alana Grajewski (USA)
Esther Hoffmann (Germany)
Konrad Schargel (Spain)
22
Coffee Break and Poster Session 4 (see page 43)

16:45 Moderators: Delphine Bifrare (Switzerland)
17:15 Poster Area
Maria Da-Luz Freitas (Portugal)
Stylianos Kandarakis (Greece)
Rapid Fires 2
16:45
17:15 Moderators: Renè Hoehn (Switzerland), Manuele Michelessi (Italy), Booth 1, 2, 3
Soledad Aguilar Munoa (United Kingdom)
Booth 1
Reversible mitochondrial injury in dying retinal ganglion cells
Wenting You, Chris Reutelingsperger, Tos Berendschot, Carroll Webers, Theo Gorgels (The
Netherlands)
Intraocular pressure changes during yoga exercises in young healthy adults
Darja Shajiei, Josephine Wachtl, Angelika Schuknecht, Lucas Bachmann, Christoph Kniestedt
(Switzerland)
Automatic goniophotography as a learning tool for gonioscopy
Chiara Pizzorno, Carlo Alberto Cutolo, Alessandro Bagnis, Michele Iester, Carlo Traverso (Italy)
Booth 2
Neurofilament light chain - a new marker for neuronal decay in the aqueous humor of glaucoma
patients
Nora Woltsche1, Katharina Valentin1, Lukas Hoeflechner1, Andreas Guttmann1, Jutta Horwath-
Winter1, Mona Schneider1, Domagoj Ivastinovic1, Marlene Lindner1, Leopold Schmetterer2, Neena
Singh3, Regina Riedl1, Arabella Buchmann1, Michael Khalil1, Ewald Lindner1 (1Austria, 2Singapore,
3
USA)
Ab-interno canaloplasty standalone versus combined with cataract surgery - 36-month outcomes in

1000+ eyes
Mahmoud Khaimi (USA)
Plasma rich in growth factors as an adjuvant agent in non-penetrating deep sclerectomy
Pedro Pablo Rodriguez-Calvo, Ignacio Rodriguez-Una, Montserrat García, Hector Gonzalez-
Iglesias, Andres Fernandez-Vega-Cueto, Jesus Merayo-Lloves (Spain)
Booth 3
Intra-ocular pressure response to dexamethasone implant injections in patients with a history of
filtering surgery: the TRABEX study
Amina Rezkallah, Philippe Denis, Kodjikian Laurent, Mathis Thibaud (France)
A biomaterial drug-eluting device for reducing post-trabeculectomy inflammation and fibrosis
Mark Lemoine, Nina Pohler, Zulal Demir, Colm O’Brien, Fergal O’Brien, Alan Hibbitts (Ireland)
Magnetic resonance imaging of glaucoma drainage devices

Rafael Correia Barão, David Berhanu, Diogo Bernardo Matos, André Diogo Barata, Rita Sousa,
Luis Abegão Pinto (Portugal)
23
“Cutting the Gordian knot” - Alexander the Great

08:00 How to manage a glaucoma suspect and OHT?
09:00 Course Director: A lain Bron (France)
Course Co-Director: Barbara Teuchner (Austria)
Plenary Room
Speakers: Alain Bron (France)
Barbara Teuchner (Austria)

08:00 Algorithm for medical treatment for glaucoma
09:00 Course Director: Luca Rossetti (Italy)
elphine Bifrare (Switzerland)
Course Co-Director: D Skalkotas
Speakers: Delphine Bifrare (Switzerland)
Dario Romano (Italy)
Luca Rossetti (Italy)

08:00 MIGS and their complications
09:00 Course Director: Norbert Pfeiffer (Germany)
Course Co-Director: Julian Garcia Feijoo (Spain) Socrates
Julian Garcia Feijoo (Spain)
Norbert Pfeiffer (Germany)

08:00 Visual fields - Interpreting those dots
nanth Viswanathan (United Kingdom)
Course Co-Director: Luis Abegão Pinto (Portugal)
Hippocrates 1
Speakers: Luis Abegão Pinto (Portugal)
Wednesday, 8 June 2022

08:00 Face-to-face or virtual management?
09:00 Course Director: Winifred Nolan (United Kingdom)
Course Co-Director: João Barbosa Breda (Portugal) Hippocrates 2
Speakers: João Barbosa Breda (Portugal)
Winifred Nolan (United Kingdom)
Andrew Tatham (United Kingdom)
24

08:00 New on structural measurement in the pipe line
09:00 Course Director: L eopold Schmetterer (Singapore)
Course Co-Director: Michele Iester (Italy) Hippocrates 3
Speakers: Michele Iester (Italy)
Eduardo Normando (United Kingdom)
Leopold Schmetterer (Singapore)

Surgery: interactive difficult cases
08:00 Course Director: H
erbert Reitsamer (Austria)
09:00 Course Co-Director: Siri Mohammed Ezzouhairi (Morocco)
Chair: Gordana Sunaric Megevand (Switzerland)
Hippocrates 4
Speakers: Zeynep Aktas (Turkey)
Siri Mohammed Ezzouhairi (Morocco)
Herbert Reitsamer (Austria)
Session 9 - The many protagonists in surgery: patients,

09:00 surgeons and referring doctors
10:30 Moderators: Stylianos Kandarakis (Greece) Plenary Room
James Kirwan (United Kingdom)
Andrew McNaught
When is phacoemulsification alone a valuable option? (United Kingdom)
How do I counsel the patient on surgery when cataract and glaucoma Stylianos Georgoulas
coexist? (United Kingdom)
David Friedman
Is restarting drops after filtering surgery “throwing in the towel”? (USA)
Anthony King
Exploring patients’ expectations (United Kingdom)
Philippe Denis
Complications: to worry or not to worry? (France)

Manuele Michelessi
Is cyclodestruction only the very last option? (Italy)
Discussion
10:40
11:10 Coffee break Exhibition Area
25
Session 10 - Don’t miss this session… it may help you
11:10 with your next patient (cases with interactive voting)
12:40 Moderators: Luis Abegão Pinto (Portugal) Plenary Room
Gordana Sunaric Mégevand (Switzerland)
Carlo E. Traverso
11:10 Clinical scenario 1 (Italy)
Discussion / round table
Keith Barton
11:25 Clinical scenario 2 (United Kingdom)
11:40 Clinical scenario 3 Julian Garcia-Feijoo

(Spain)
Stefano Gandolfi
11:55 Clinical scenario 4 (Italy)
Ingeborg Stalmans
12:10 Clinical scenario 5 (Belgium)
12:25 Round table
Closing Remarks
12:45 Plenary Room
Fotis Topouzis (Greece), Ingeborg Stalmans (Belgium)
12:45 Farewell Reception

26
Sunday 5 June 2022
10:15
10:45 Poster Session 1 Poster Area
Diagnosis | Pathogenesis
Moderators: Carlo Alberto Cutolo (Italy), Sophie Lemmens (Belgium), Eleni Nikita (United Kingdom)
P1.01 Acute angle closure glaucoma after major surgery: a case series
Marta Correia, Mariana Portela, Margarida Baptista, Maria Patricio (Portugal)
P1.02 T he Manchester Triage System in the acute primary angle closure attack
Margarida Ribeiro, João Barbosa-Breda, Ana Faria-Pereira, Francisco Gonçalves, Flávio Alves,
Sérgio Silva, Fernando Falcão-Reis, Antonio Melo (Portugal)
P1.03 Acute angle closure glaucoma within “normal” IOP. A case of PISK
Carolina Rius Tornes, Teresa Florit Pons, Marc Rosell Raventos, Celia Fuste Fusares (Italy)
P1.04 Tramadol subcutaneous injection inducing simultaneous bilateral acute angle-closure glaucoma
Nada Sakli, Mbarek Sameh (Tunisia)
P1.05 S econdary angle closure glaucoma secondary to 360 degrees DALK-iris adherences by AS-OCT imaging
Nikistratos Yfantis, Julia Fajardo Sanchez, Lauren Van Lancker, Jia Ng, Emma Hollick, Lana Fu, Avi
Kulkarni (United Kingdom)
P1.06 Risk factors for suprachoroidal hemorrhage associated with glaucoma surgery in children: a case-control
study
Rakan Algorinees1, Rizwan Malik1,2 (1Saudi Arabia, 2Canada)
P1.07 M
yopic tilted disc by optical coherence tomography. Myopic or glaucoma optical neuropathy?
Svetlana Zhukova, Tatiana Iureva (Russian Federation)
P1.08 S tress-Strain Index (SSI): an index to take into account in thick CCT patients
Miguel Teus Guezala, Marta I. Martinez-Sanchez, Gema Bolivar, Javier Paz-Moreno-Arrones (Spain)
P1.09 Study on the prediction of glaucoma progression in patients associated with sleep apnea using artificial
intelligence tools
Nicoleta Anton, Bogdan Doroftei, Catalin Lisa, Camelia Bogdanici, Roxana Ciuntu (Romania)
P1.10 R
elationship between foveal avascular zone and macular vessel density with central visual field in
glaucoma patients
Laura Díez-Álvarez, Laia Jaumandreu, Fernando José Huelin Alcubierre, Cristina Ye Ye Zhu, Ana Diaz
Montealegre, Elisa González Pastor, Gema Rebolleda, Francisco José Muñoz Negrete (Spain)
P1.11 False-positive classification and associated factor in segmented macular layers and retinal nerve fiber
layer analysis: a spectralis OCT deviation map study
Yun Jeong Lee, Jin Wook Jeoung (South Korea)
P1.12 Neurofilament light chain - a new marker for neuronal decay in the aqueous humor of glaucoma
patients
Nora Woltsche1, Katharina Valentin1, Lukas Hoeflechner1, Andreas Guttmann1, Jutta Horwath-
Winter1, Mona Schneider1, Domagoj Ivastinovic1, Marlene Lindner1, Leopold Schmetterer2, Neena
Singh3, Regina Riedl1, Arabella Buchmann1, Michael Khalil1, Ewald Lindner1 (1Austria, 2Singapore,
Poster Sessions
3
USA)
P1.13 M
yopic normative database assessment of the retinal nerve fiber layer thickness using spectralis OCT
Hayati Yilmaz, Yagmur Seda Yesiltas, Emre Aydemir, Gözde Aksoy, Gülce Gökgöz Özısık, Mehmet
Talay Koylu, Ismail Çagatay Çaglar, Atilla Bayer (Turkey)
27
P1.14 P
upillography measurements in patients with asymmetric glaucomatous damage and their correlations
with structural and functional glaucoma parameters
Banu Bozkurt, Yalçın Karaküçük, Ayşe Bozkurt Oflaz, Sona Gorchuyeva (Turkey)
P1.15 Glaucoma: is it though?

Alexandra Trivli, Evangelia Dalieraki, Eleni Giakoumogiannaki, Ilias Vasilaras (Greece)
P1.16 Developing the intra-ocular pressure metrology in Europe

Dominik Pražák1, Šejla Ališic2, Anatolii Bescupschii3, Alen Bošnjakovic2, Serghei Ceapa3, Ehlimana
Jugo2, Vanco Kacarski4, Nenad Petrovski4, Václav Sedlák1, Alina Sincarenco3, Bianka Stoilkovska4,
Vítezslav Suchý1, Radovan Wiecek1 (1Czech Republic, 2Bosnia and Herzegovina, 3Macedonia)
P1.17 G
laucomatocyclitic crisis “Posner-Schlossman Syndrome”: a case report
Brenda Alegría García Loza, Rodrigo Mateos Oropeza (Mexico)
P1.18 C oexistence of normal tension glaucoma and pigment dispersion syndrome manifestations in a female
patient. Case report and literature overview
Elpida Kollia1, Alexandros Chatzirallis2, Theodora Gianni2, Konstantina Koumoutsou2, Diafa
Aspasia2, Eleni Patsea2 (1United Kingdom, 2Greece)
P1.19 A
utomated segmentation of retinal nerve fiber layer excluding retinal blood vessels: integrating OCT and
OCT angiography
Valentina Folegani1, Matteo Airaldi1, Jonathan Oakley2, Sara Bochicchio1, Angelica Dipinto1,
Simona Prandoni1, Giovanni Staurenghi1, Giacinto Triolo1 ( Italy, 2USA)
P1.20 Automatic goniophotography as a learning tool for gonioscopy

Chiara Pizzorno, Carlo Alberto Cutolo, Alessandro Bagnis, Michele Iester, Carlo E. Traverso (Italy)
P1.21 A
utomated digital gonioscopy in a real world clinical setting
Sundeep Deol, Andrew Tatham (United Kingdom)
P1.22 Influence of altitudinal visual field analysis on reproducibility of visual field sensitivity in glaucoma
Daisuke Shiba, Sayaka Adachi, Akiko Hanyuda, Motohiro Moriya, Kenya Yuki1 Kazuno Negishi
(Japan)
P1.23 O
CT angiography images evaluation in healthy and glaucomatous subjects using a new data analysis
program: inter-image variability
Paola Cassottana, Costanza Iester, Lorenzo Ferro Desideri, Carlo E. Traverso, Michele Iester (Italy)
P1.24 C omparison of intraocular pressure, central corneal thickness and ocular biomechanical metrics
using Corvis ST, Goldmann applanation tonometer and ultrasound pachymeter in healthy and ocular
hypertensive patients
Elena Ávila Marrón, Maria Del Mar Schilt Catafal, Elena Milla, Susana Duch (Spain)
P1.25 Clinical comparison between Swedish Interactive Thresholding Algorithm (SITA) Faster 24-2C and SITA
Standard 24-2 in glaucomatous patients
Luca Di Cello, Daniele Sindaco, Federica Tessitore, Giulia Agosto, Carlo Alberto Cutolo, Aldo Vagge,
Carlo E. Traverso, Michele Iester (Italy)
P1.26 Q
uantification and functional correlations of macular microvasculature in the ganglion cell-inner
plexiform layer in primary open angle glaucoma using OCT angiography
Ingy Ingymadi (USA)
P1.27 C linical usefulness of layer-by-layer deviation maps of spectralis OCT: comparison with cirrus OCT
Sooyeon Choe, Mirinae Jang, Young Kook Kim, Ki Ho Park, Jin Wook Jeoung (South Korea)
P1.28 O
ptical coherence angiography of optic disc in eyes with primary open-angle glaucoma and normal-
tension glaucoma with equal levels of structural damage
Poster Sessions
Ioannis Halkiadakis, Spiros Atzamoglou, Nikos Koukos, Vasilis Tzimis, Michalis Tzakos (Greece)
P1.29 C atch trials in advanced glaucoma: general glaucoma or macular program

Dragan Janjic (Serbia)
28
P1.30 R
etinal nerve fiber layer defect on optical coherence tomography en face image is more closely related
with visual field indices than conventional red-free fundus photography
Hyuk Jin Choi, Jin-soo Kim (South Korea)
P1.31 D
iagnostic accuracy and relationship between optical coherence tomography angiography vessel density
and structural/functional parameters in healthy, preperimetric and manifest glaucoma eyes
Asma Khallouli, Yassin Weslati, Dhouha Gouider, Afef Maalej, Riadh Rannen (Tunisia)
P1.32 L ong-term outcomes of standalone excisional goniotomy using the Kahook Dual Blade in eyes with
primary open-angle glaucoma
Theresa Landry, Mohammed Kamal Elmallah, Blake Williamson, Cade Nelson (USA)
P1.33 E valuation of the diagnostic accuracy of different tomographic parameters by SD-OCT in preperimetric
and perimetric stage of glaucoma
Afef Maalej, Yassin Weslati, Dhouha Gouider, Asma Khallouli, Riadh Rannen (Tunisia)
P1.34 C orrelation between parameters of Bruch’s membrane opening, retinal nerve fiber layer and ganglion
cell complex
Maria Liseth Salazar Quiñones, Carmen Mendez-Hernandez, Julian Garcia Feijoo, Rafael Sánchez
del Hoyo (Spain)
P1.35 R
eproducibility of optic nerve head and macular vessel density by Heidelberg Spectralis II optical
coherence tomography angiography (OCT-A) in glaucoma and healthy subjects
Maria Liseth Salazar Quiñones, Jose Ignacio Fernandez-Vigo, Pilar Peña-Urbina, Jose Martinez-de-
la-Casa, Julian Garcia Feijoo (Spain)
P1.36 C ontrast sensitivity in glaucoma patients with visual field defects in different locations
Jiyong Jang, Eun Ji Lee (South Korea)
P1.37 O
CT (RNFL, GCC) findings in glaucoma clinic patients with normal visual field tests: how to approach and
treat
Chrysanthos-Christos Laoudikos, Chryssa Terzidou, Vassilios Kozobolis (Greece)
P1.38 E valuation of ganglion cell parameters and comparison with retinal nerve fiber layer in preperimetric
glaucoma, early stage glaucoma and healthy people
Özlem Aktas Özaltun, Özlem Gürbüz Köz (Turkey)
P1.39 S tructure-function correlation between OCT and both Visual Field SITA Standard and SITA Faster
Federica Tessitore, Daniele Sindaco, Giulia Agosto, Martina Mercuri, Carlo Alberto Cutolo, Carlo E.
Traverso, Michele Iester (Italy)
P1.40 D
ifferentiating chiasmal macroadenoma from primary open angle glaucoma by optical coherence
tomography
Seyda Ugurlu, Turan Akbalık, Gonca Oruk (Turkey)
P1.41 A
ssociation between retinal vascular parameters and retinal nerve fiber layer thickness in open angle
glaucoma: the ALIENOR population-based study
Catherine Helmer, Melanie Le Goff, Marie-Noelle Delyfer, Marie-Benedicte Rougier, Jean-François
Korobelnik, Audrey Cougnard-Gregoire, Cecile Delcourt, Cédric Schweitzer (France)
P1.42 E clectic risk factors for ocular hypertension and glaucoma patients in the Iberian Peninsula
Maria Dolores Pinazo Duran, Jose Miguel Bolarin-Guillen, Carolina Garcia Villanueva, Jose Javier
Garcia-Medina, Jose Manuel Salgado-Borges, Helena Cristina Campos-Borges, Juan Francisco
Ramos-Lopez, Elena Rodriguez-Neila, Elena Bendala-Tufanisco, Vicente Zanón-Moreno (Spain)
case of idiopathic iridoschisis

P1.43 A
Massimo Savastano (Italy)
Poster Sessions
P1.44 M
icrospherophakia in Weill-Marchesani syndrome, the ophthalmologist should not be missed
Kulawan Rojananuangnit (Thailand)
29
P1.45 C omplications after dexamethasone intravitreal implant in diabetic macular edema patients
Almudena Moreno Martínez, Cristina Blanco Marchite, Francisco López Martínez, Antonio Donate
Tercero, Carlos Cava Valenciano, Eva Gonzalez Aquino, Sergio Copete Piqueras (Spain)
P1.46 O
ptic disc structural and functional assessment in patients with primary Raynaud’s phenomenon
Ana Rita Carreira, Nadine Marques, Pedro Carreira, Filipe Moraes, Tomas Loureiro, Sandra
Rodrigues-Barros, Paula Saldanha, João Cardoso, Nuno Campos (Portugal)
P1.47 O
CT in optic disc drusen: what do we have to look at?
Laura Sánchez Vela, Marta Garrido Marín, Alejandro Pardo Aranda, Rafael Fischer, Olivia Pujol
Carreras, Manuel Antonio Amilburu Pérez, Jaume Rigo, Antoni Dou, Marta Castany (Spain)
P1.48 B
ilateral choroidal detachment in the absence of previous intraocular surgery: a case series
Maria Jesus Chaves Samaniego (Spain)
P1.49 T he relationship between cerebrovascular autoregulation and retrobulbar blood flow in glaucoma
patients
Evelina Simiene, Akvile Stoškuviene, Lina Šiaudvytyte, Ingrida Januleviciene (Lithuania)
P1.50 Structure-function analysis of the peripapillary intrachoroidal cavitation

Artemise Dugauquier, Wilfried Tchatchou Tomy, Nacima Kisma, Kevin Coppens, Yassir Alaoui
Mhammedi, Karelle Leroy, Francoise Bremer, Adele Ehongo Bidime (Belgium)
P1.51 P
rotein kinase C regulates hypoxia-induced effects on NMDAR-mediated excitatory retinocollicular
neurotransmission in the in vitro model of central retinal projections
Hanna Dumanska, Nickolai Veselovsky (Ukraine)
P1.52 E LAVL1/HuR is required for both endo- and exogenous neuroprotection in retinal ganglion cells
Anna Pacwa1,2, Joanna Machowicz1, Piotr Rodak1, Bartosz Machna1, Saeed Akhtar2, Marita
Pietrucha-Dutczak1, Marialaura Amadio3, Joanna Lewin-Kowalik1,2, Adrian Smedowski1,2 (1Poland,
2
Saudi Arabia, 3Italy)
P1.53 R
ole of the integrated stress response in glaucoma
Caoimhe Normile, Mustapha Irnaten, David Simpson, Oisín Cappa, Boris Kholodenko, Vadim
Zhernovkov, Colm O’Brien (Ireland)
P1.54 U
ltrastructural visualization of lymphatic vessels of filtration blebs after non-penetrating glaucoma
surgery
Tatiana Iureva, Yulia Malisheva (Russian Federation)
educed mitochondrial DNA copy number in peripheral blood lymphocytes of POAG patients
P1.55 R
Antoni Vallbona Garcia, Ilse Hamers, Florence van Tienen, Irenaeus de Coo, Carroll Webers, Hubert
Smeets, Theo Gorgels (The Netherlands)
P1.56 U
nusual extreme seasonal intraocular pressure (IOP) fluctuation in primary open-angle glaucoma (POAG)
Dimitra Oikonomou, Petko Hristov, Aggeliki Androu, Antonios Manolakis, Dimitrios Alonistiotis
(Greece)
P1.57 T he effect of miR-29b expression on ADAM12 & ADAM19 in the lamina cribrosa in primary open angle
glaucoma
Aoife Smyth, Breedge Callaghan, Darrell Andrews, Mustapha Irnaten, Colin Willoughy, Colm
O’Brien (Ireland)
P1.58 R
esolution of hypotony related peripapillary retinoschisis in a glaucoma patient with normalization of
intraocular pressure
Ioannis Markopoulos, Ioannis Halkiadakis, Anna Vernikou, Michalis Tzakos (Greece)
P1.59 G
eneration of human retinal ganglion cells for glaucoma disease modeling
Poster Sessions
Theo Gorgels, Iris Boesten, Florence van Tienen, Hubert Smeets, Carroll Webers, Birke Benedikter
(The Netherlands)
P1.60 Changes in blood flows in the central retinal artery secondary to IOP reduction in open angle glaucoma
measured by Holographic Doppler
Régis Lecoge, Michael Atlan, Léo Puyo, Emmanuelle Brasnu-De Cenival, Luzu Jade, Michel Paques,
Christophe Baudouin, Labbé Antoine (France)
30
P1.61 T he role of AMP-related kinase 5 (ARK 5) inhibition in human glaucomatous lamina cribrosa cells
Sarah Powell1, Breedge Callaghan2, Mustapha Irnaten1, Colin Willoughy2, Colm O’Brien1 (1Ireland,
2
United kingdom)
P1.62 P
rimary open-angle glaucoma patients have reduced systemic mitochondrial function compared to
healthy controls
Bledi Petriti, Kai-Yin Chau, Alessandro Rabiolo, Gerassimos Lascaratos, David Garway-Heath (United
Kingdom)
P1.63 Autotaxin in the lamina cribrosa: a driver of fibrosis in glaucoma
Amy O’Regan, Sarah Eivers, Mustapha Irnaten, Deborah Wallace, Colm O’Brien (Ireland)
P1.64 P
aired analysis of mitochondrial DNA variants in primary open angle glaucoma: the role of somatically
acquired mutations
Neeru Vallabh, Brian Lane, David Simpson, Marc Fuchs, Anshoo Choudhary, Colin Willoughy (United
Kingdom)
P1.65 A
connection between serum levels of HSP 70 and parameters of structural and functional glaucoma
damage
Marija Trenkic, Predrag Jovanovic, Jasmina Djordjevic-Jocic, Marija Radenkovic, Maja Petrovic
(Serbia)
P1.66 P
seudophakic pupillary block
Pablo Cisneros, Ismael Bakkali El Bakkali, Eva Josefina Núñez Moscarda, Juan Ibañez (Spain)
P1.67 N
eovascular glaucoma due to ocular ischemia syndrome. Case report and differential diagnosis
Elizabeth Salcedo, Gloria Biarge, Beatriz Rodriguez, Barbara Delas Alos, Mouafk Asaad (Spain)
P1.68 S econdary intraocular hypertension due to increased episcleral venous pressure – different etiologies and
pathophysiological mechanisms
Margarida Baptista, Marta Correia, Mariana Portela, Maria Picoto, Pedro Arede (Portugal)
P1.69 R
egulation of lysyl oxidase-like protein 1 by microRNAs in pseudoexfoliation glaucoma
Alka Khera, Surinder Pandav, Faisal TT, Jagat Ram (India)
P1.70 O
ptic nerve head changes in eyes treated with multiple intravitreal injections
João Garrido, Inês Passos, Diogo Fortunato, Olga Berens, Augusto Candeias (Portugal)
P1.71 C omparison of machine learning approaches for focal visual field modelling
Damon Wong1,2, Jacqueline Chua1, Inna Bujor3, Alina Popa-Cherecheanu3,4, Leopold Schmetterer1,2,5
(1Singapore, 2Switzerland, 3Romania, 4Romania, 5Austria)
P1.72 T he discriminative ability of two glaucoma diagnostic calculators in glaucoma suspects and glaucoma
patients
Nestor Ventura Abreu, Marc Biarnés, Sofía Batlle, Maria Teresa Carrión Donderis, Rafael Castro
Domínguez, Javier Moreno Montañes, Marta Pazos (Spain)
P1.73 R
eversible mitochondrial injury in dying retinal ganglion cells
Wenting You, Chris Reutelingsperger, Tos Berendschot, Carroll Webers, Theo Gorgels (The
Netherlands)
P1.74 Intraocular pressure changes during yoga exercises in young healthy adults
Darja Shajiei, Josephine Wachtl, Angelika Schuknecht, Lucas Bachmann, Christoph Kniestedt
(Switzerland)
P1.75 Increased risk of Alzheimer’s disease in patients with normal tension glaucoma: a nationwide cohort
study
Yu Yen Chen1,2, Man Chen Hung1 (1Taiwan, 2USA)
Poster Sessions
P1.76 Association between retinitis pigmentosa and an increased risk of open angle glaucoma
Man Chen Hung1, Yu Yen Chen1,2 (1Taiwan, 2USA)
31
Monday, 6 June 2022
10:40
Treatment - Medical | Epidemiology, Health Economics, Visual Disability, QoL | Follow up/Progression
Moderators: Hana Abouzeid (Switzerland), Eleftherios Anastasopoulos (Greece), Muriel Poli (France)
P2.01 A new paradigm targeting two glaucoma therapy dilemmas

Anastasios G. Konstas1, Konstadinos G. Boboridis1, Georgios Athanasopoulos1, Anna-Bettina
Haidich1, Irini C. Voudouragkaki1, Eirini Pagkalidou1, Andreas Katsanos1, L. Jay Katz2 (1Greece, 2USA)
P2.03 R
esponder rate and investigator/patient-reported assessment of efficacy and tolerability regarding the
preservative-free tafluprost/timolol fixed-dose combination in the treatment of open-angle glaucoma
and ocular hypertension: country-level analysis from the VISIONARY study
Gabor Hollo1, James Kirwan2, Fernando Lopez-Lopez3, Marina Zimina4, Claudia Fassari5, Francesco
Oddone6 (1Hungary, 2United Kingdom, 3Spain, 4Russian Federation, 5Switzerland, 6Italy)
P2.04 B
aseline intraocular pressure affects treatment outcome with the preservative-free tafluprost/timolol
fixed-dose combination in open angle glaucoma and ocular hypertension: subanalysis from the
VISIONARY study
Gabor Holló1, James Kirwan2, Fernando Lopez-Lopez3, Marina Zimina4, Claudia Fassari5, Francesco
Oddone6 (1Hungary, 2United Kingdom, 3Spain, 4Russian Federation, 5Switzerland, 6Italy)
P2.05 P
ractice patterns for the treatment of glaucoma - Results from a survey among German
ophthalmologists
Christian Wolfram, Alexander Schuster (Germany)
P2.06 U
ltrasound ciliary plasty in glaucoma treatment: a long-term follow-up study
Bartlomiej Bolek, Adam Wylegala, Edward Wylegala (Poland)
P2.07 T he protective role of fluvoxamine in fibrotic disorders of the eye

Minh Tran, Balázs Besztercei, Gyorgy Torok, Timea Medveczki, Illes Kovacs, Attila Szabo, Andrea
Fekete, Judit Hodrea (Hungary)
P2.08 T he impact of MF-438 on the latent inflammation induced by preservative-free prostaglandin analog
eyedrops
Joanna Machowicz1, Anna Pacwa1, Alicja Wojtyniak1, Marita Pietrucha-Dutczak1, Elisa Toropainen2, Ali
Koskela1, Ewa Mrukwa-Kominek1, Joanna Lewin-Kowalik1, Adrian Smedowski1 (1Poland, 2Finland)
P2.09 Incidence and factors associated with brimonidine allergy

Pattawee Pongpisitkul, Sunee Chansangpetch, Kitiya Ratanawongphaibul, Rath Ittipanichpong,
Anita Manassakorn, Visanee Tantisevi, Prin Rojanapongpun (Thailand)
P2.10 P
atient adherence to glaucoma medication in glaucoma virtual clinic
Su Ling Young, Kelvin Cheng, Andrew Tatham (United Kingdom)
P2.11 C orrelating symptomatic ocular surface disease with clinical signs in glaucoma patients on chronic
intraocular pressure lowering eyedrops
Fiona Pin Miao Lim, Catherine Willshire, Rupert Bourne (United Kingdom)
P2.12 A
nterior segment optical coherence tomography for tear meniscus evaluation and its correlation with
number of glaucoma medications
Lidija Magarasevic, Isidora Janicijevic, Milos Plavsic (Serbia)
Poster Sessions
P2.13 A
queous misdirection post phaco-trab: AS-OCT imaging and successful management
Miguel Leitão, Francisco Alves, Guilherme Almeida (Portugal)
P2.14 E ffects of erythropoietin on neuroprotection in an experimental glaucoma model

Tolga Kocaturk, Yusuf Onay, Sinan Bekmez, Serhan Camoglu, Kemal Ergin (Turkey)
32
P2.15 F unctional analysis of glia cells in RGC using coculture system

Ji-Ae Ko, Akira Minamoto, Kaori Komatsu, Hideaki Okumichi, Yoshiaki Kiuchi (Japan)
P2.16 E valuation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex-
vivo retinal explant model
Juliette Buffault, Reboussin Elodie, Brignole-Baudouin Françoise, Réaux-Le Goazigo Annabelle,
Mélik-Parsadaniantz Stéphane, Christophe Baudouin (France)
P2.18 In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride
María Silvia Passerini, Florencia Sabbione, Alexia Vereertbrugghen, Melina Sol del Papa, Jeremias
Galletti (Argentina)
P2.19 Intraoperative OCT-assisted ophtalmic surgeries and it´s novel use in open angle glaucoma surgery: cases
report
Jose Manuel Rodriguez Perez, Brenda Alegría García Loza (Mexico)
P2.20 B
imatoprost implant effects on 24-hour intraocular pressure
Miriam Kolko1, Robert Weinreb2, William C. Christie2, Felipe Medeiros2, Randy Craven2, Kimmie
Kim2, Ashley Nguyen2, David Wirta2 (1Denmark, 2USA)
P2.21 E fficacy and drug tolerability of preservative-free latanoprost-timolol fixed combination in glaucoma
and ocular hypertension patients with existing ocular surface disease switched from the preserved
prostaglandin analog-timolol fixed combinations
Sonja Jandrokovic, Sania Vidas Pauk, Dina Lešin Gacina, Ivan Škegro, Martina Tomic (Croatia)
P2.22 T he effect of antiglaucomatous drugs on central corneal thickness in patients with primary open-angle
glaucoma: 5-year results of 1152 patients. Retroprospective study
Mehmet Tahir Eski, Taha Sezer (Turkey)
P2.23 Extended duration of IOP lowering with bimatoprost implant in a phase 3 clinical trials study extension
Andrew Tatham1, Felipe Medeiros2, W. Daniel Stamer Stamer2, Saumya Nagar2, Marina Bejanian2,
Suzanne Zheng2, Michael R. Robinson2, David Wirta2 (1United Kingdom, 2USA)
P2.24 W
ound healing response after minimally invasive glaucoma surgery in the rabbit
Ralph van Mechelen1, Marjolein Verhesen-Herfs1, Marion Gijbels1, Christian Bertens1, Leonard
Pinchuk2, Theo Gorgels1, Henny Beckers1 (1The Netherlands, 2USA)
P2.25 The influence of anti-hypertensive eye drops and preservatives in the ocular surface of primary open-
angle glaucoma patients
André Ferreira, Ana Marta, João Heitor Marques, Catarina Castro, Diana José, Paulo Sousa, Isabel
Neves, Maria João Menéres, Irene Barbosa (Portugal)
P2.26 M
agnesium supplementation does not influence circumpapillary vessel density in normal-tension
glaucoma
Lukas Hoeflechner1, Thomas Falb1, Laura Posch-Pertl1, Katharina Valentin1, Marlene Lindner1, Bujar
Berisha1, Leopold Schmetterer1,2,3, Gernot Steinwender1, Domagoj Ivastinovic1, Nairz Manfred1,
Stephanie Sarny1, Wolfgang List1, Ewald Lindner1 (1Austria, 2Singapore, 3Switzerland)
P2.27 T he effect of metformin on glaucoma lamina cribrosa cells

Daire Hurley, Sophia Millington-Ward, Mustapha Irnaten, Gwyneth Jane Farrar, Colm O’Brien (Ireland)
P2.28 T wo-year results from a European Study of a supraciliary glaucoma drainage device in patients with open
angle glaucoma
Philippe Denis1, Christoph Hirneiß2, Julian Garcia Feijoo3, Florent Aptel2, Burkhard Dick2, Norbert
Pfeiffer2 (1France, 2Germany, 3Spain)
P2.29 E ye surface status after therapeutic switch from bimatoprost 0.1 mg/ml with benzalkonium chloride
Poster Sessions
or bimatoprost 0.3 mg/ml preservative-free to a new bimatoprost 0.1 mg/ml preservative-free: an

observational study
Mariaelena Filippelli, Nicola Ciampa, Roberta Giannini, Gaetano Fioretto, Pier Franco Marino,
Roberto dell’Omo, Giuseppe Campagna, Ciro Costagliola (Italy)
33
P2.31 E fficacy and tolerability of netarsudil 0.02%/latanoprost 0.005% compared with bimatoprost 0.03%/
timolol 0.5% in patients with open-angle glaucoma or ocular hypertension: findings from the MERCURY 3
study
Ingeborg Stalmans1, Gabor Holló2, Anton Hommer3, Jose I. Belda4, Francesco Oddone5 on behalf of
the MERCURY 3 Study Group (1Belgium, 2Hungary, 3Austria, 4Spain, 5Italy)
P2.32 P
reliminary results of a new long-tube glaucoma drainage device made from innovative materials: a
short-term rabbit study
Christian Bertens, Ralph van Mechelen, Leonard Pinchuk, Jan de Boer, Jaap den Toonder, Henny
Beckers (The Netherlands)
P2.33 M
anagement of uveitic glaucoma in South East of Serbia
Jasmina Djordjevic-Jocic, Predrag Jovanovic, Marija Trenkic, Sonja Cekic, Maja Zivkovic, Marija
Radenkovic (Serbia)
P2.35 M
ultiple surgical approach to ICE syndrome: report of an unexpected event
Jacobo Herrera Pereiro, Laura Guerrero Altares, José Javier San Román Llorens (Spain)
P2.36 T raumatic hyphema and angle recession without glaucomatous optic neuropathy: a case report
Alejandro Pardo Aranda, Laura Sánchez Vela, Marta Garrido Marín, Rafael Fischer, Manuel Antonio
Amilburu Pérez, Olivia Pujol Carreras1, Jaume Rigo Quera, Marta Castany, Antonio Dou Sáenz de
Vizmanos (Spain)
P2.37 P
eculiarity of the glaucoma care in Ukraine
Zoya Veselovskaya, Natalia Veselovskaya, Inna Zaporozhchenko (Ukraine)
P2.38 P
sychological aspects related to glaucoma in a developing country
Farah Akhtar, Madiha Aruj, Mahmood Ali (Pakistan)
P2.39 P
rescription burden of antiglaucoma drugs in a developing country
Farah Akhtar, Mahmood, Muhammad Sadiq (Pakistan)
P2.40 U
nder-registration of visual impairment in glaucoma patients: why aren’t we doing enough?
Omar Mostafa, Onyinye Akpenyi, Jaishree Gandhewar (United Kingdom)
P2.41 Influence of pharmacological group in adherence to glaucoma medications in a wide population

Ignacio Pereira Gonzalez, Javier Benitez-del-Castillo Sanchez, Soledad Jimenez-Carmona, Juan
Antonio Cordoba Doña (Spain)
P2.42 Influence of preservatives and dose-format in adherence to glaucoma medications in a wide population
Javier Benitez-del-Castillo Sanchez, Ignacio Pereira Gonzalez, Soledad Jimenez-Carmona, Juan
Antonio Cordoba Doña (Spain)
P2.43 P
revalence of ocular hypertension/secondary glaucoma in uveitis
Irene Temblador-Barba, Javier Benitez-del-Castillo Sanchez, Alejo Rodriguez-Suarez, Alfredo
Michan-Doña (Spain)
P2.44 T he recruitment process of an epidemiology study amidst the COVID19 pandemic: experience,
challenges, learning points and preliminary data on glaucoma epidemiology
David Agius, Xeniya Fedoryak, Julian Mamo, Francis Carbonaro (Malta)
P2.45 P
ublication and outcome reporting bias based on the registration status in glaucoma surgical trials: a
systematic review
Reinemary Michael, Andrew Toren, Cape Leila, Hui Xin Zhang (Canada)
Poster Sessions
34
P2.46 E liciting preferences in glaucoma management - a systematic review of stated-preference studies

Lotte M.J. Scheres, Mickaël Hiligsmann, Brigitte Essers, Henny Beckers (The Netherlands)
P2.47 Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with
glaucoma
Lee Jones, Natalia Maes, Umair Qidwai, Gokulan Ratnarajan (United Kingdom)
P2.48 G
laucoma clinical research: trends in treatment strategies and drug development
Thuy Linh Tran, Line Storgaard, Josefine Clement Freiberg, Alexander Hauser, Miriam Kolko
(Denmark)
P2.49 C orrelation between iris color and glaucoma type
Marija Bozic, Ivan Marjanovic, Vesna Maric (Serbia)
P2.50 A
n audit to assess if our patients with glaucoma have informed the driving and vehicle licensing agency
Michelle Dinsdale, Hussameddin Muntasser, Anshoo Choudhary (United Kingdom)
P2.51 F actors associated with corneal hysteresis in an elderly population: the Thessaloniki Eye Study
Rodanthi Christina Bartzoulianou1, Anne L. Coleman2, Alon Harris2, M. Roy Wilson2, Anna-Bettina
Haidich1, Theofanis Pappas1, Dimitrios Giannoulis1, Fei Yu2, Anastasia Raptou1, Grigoria Tzoanou1,
Fotis Topouzis1 (1Greece, 2USA)
P2.52 R
emote decision-making: the outcomes of a shifting paradigm
Diogo Matos, Rafael Correia Barão, Patrícia José, Miguel Santos, Rui Ferreira, André Diogo Barata,
Luis Abegão Pinto (Portugal)
P2.53 The performance of vertical cup-disc ratio on glaucoma diagnosis in a prevalence survey
Angeliki Salonikiou1, Anne L. Coleman2, M. Roy Wilson2, Alon Harris2, Panayiota Founti1,3,
Vassileios Kilintzis1, Eleftherios Anastasopoulos1, Fei Yu2, Theofanis Pappas1, Fotis Topouzis1
(1Greece, 2USA, 3United Kingdom)
P2.54 Sociodemographic characteristics of glaucoma patients and quality of life in glaucoma
Gizem Sayar Bilgin, Serife Bayraktar, Belgin Izgi (Turkey)
P2.55 Q
uality of life in patients requiring treatment for glaucoma and ocular hypertension: a time trade-off
study
Atika Safitri1, Evgenia Konstantakopoulou1,2, Kuang Hu1, Gus Gazzard1 (1United Kingdom, 2Greece)
P2.56 D
ietary nitrate intake is associated with decreased incidence of open-angle glaucoma
Joëlle Vergroesen1, Tosca de Crom1, Lauren Blekkenhorst2, Trudy Voortman1, Caroline Klaver1,3,
Wishal Ramdas1 (1The Netherlands, 2Australia, 3Switzerland)
P2.57 A
ssessment of the impact of an add-on and its smartphone application on the daily management of
glaucoma: a pilot study
Alice Bodeveix, Jean-Baptiste Dériot, Emmanuelle Albertini (France)
P2.58 C ost-utility of trabecular bypass at the time of cataract surgery in a universal, single-payer health care
system
Alp Atik1, Eamonn Fahy2 (1Australia, 2United Kingdom)
P2.60 IOP elevation after intravitreal injections with Ozurdex

Alberto Chierigo, Carlo Alberto Cutolo, Donatella Musetti, Raffaella Rosa, Massimo Nicolò, Carlo E.
Traverso (Italy)
P2.61 S econdary glaucoma in patients with familial amyloid polyneuropathy in Cyprus

Katia Papastavrou, Brian Gilbert Vinh, Eleni Papanicolaou Zamba, Theodoros Kyriakides,
Theodoros Potamitis (Cyprus)
Poster Sessions
P2.62 T eaching home tonometry using a remote video link

Catriona Barbour-Hastie, Andrew Tatham (United Kingdom)
P2.63 A
retrospective study to assess visual field improvement following augmented trabeculectomy
Clarissa Ern Hui Fang, Mohamad Tawfeek Hakim, Mubashir Siddiqui, Deborah Armstrong, Vikas
Shankar (United Kingdom)
35
P2.64 G
laucoma app as a tool for improvement of patients compliance
Zhamilya Sangilbayeva, Neilya Aldasheva (Kazakhstan)
P2.65 E arly detection of rapid glaucoma progression in elderly patients: a retrospective clinical study on 474
patients
Sidi Mohammed Ezzouhairi, Leila Naciri, Roula Jomaa (Morocco)
P2.66 U
se of a novel diagnostics sign-posting tool to streamline glaucoma virtual reviews
Binita Panchasara, Daniel Porter, Arnav Srivastava, Akil Kanani, Jason Chan, Lydia Chang (United
Kingdom)
P2.67 E ffect of repeated intravitreal injections in glaucoma spectrum diseases
Rodrigo Vilares-Morgado1, Vera Correia1, Ana Filipa Moleiro1, Flávio Alves1, Antonio Melo1, Sérgio
Silva1, Joana Rodrigues Araújo1, João Tavares-Ferreira1, Marta Silva1, Amândio Rocha-Sousa1,
Ângela Carneiro1, João Barbosa Breda1,2 (1Portugal, 2Belgium)
P2.68 C oncordance of intraocular pressure values obtained with the iCare HOME 2 and Goldmann applanation
tonometry in healthy subjects
Josephine Wachtl, Darja Shajiei, Angelika Schuknecht, Lucas Bachmann, Christoph Kniestedt
(Switzerland)
P2.69 O
cular surface disease in virtual glaucoma clinic patients
Su Ling Young, Kelvin Cheng, Sarah Donaldson, Tej Rane-Malcolm, Andrew Tatham (United
Kingdom)
P2.70 M
ultiple MIGS: a retrospective comparative study
Mohammed Abu-Bakra, Abdus Samad Ansari (United Kingdom)
P2.71 L ong-term follow-up for patients with primary congenital glaucoma in Latvia
Eva Elksne, Arturs Ozolins, Sandra Valeina (Latvia)
P2.72 A
ssociation between vascular and structural parameters by optical coherence tomography angiography
in primary congenital glaucoma
Laura Morales-Fernandez, Cristina Ginés Gallego, Pilar Pérez García, José María Martínez-De-La-
Casa, Julian Garcia Feijoo (Spain)
acular and peripapillary angio OCT in subjects affected by chronic open angle glaucoma with localized
P2.73 M
perimetric damage
P2.74 T he forgotten follow up
Stefan Stefanov (Bulgaria)
P2.75 G
laucoma risk prediction in ocular hypertension (GRIP): a real world data study using electronic medical
records to validate a risk predictor for conversion to glaucoma
Augusto Azuara-Blanco1, on Behalf of the GRIP study group GRIP (United Kingdom)
P2.76 C omparison of iCare home rebound tonometry and clinic intraocular pressure measurement
Jasna Pavicic-Astalos, Emmanuel Ankamah, Rachel Taheny, Eugene Ng (Ireland)
P2.77 M
acular capillary perfusion density and macular vessel density in open angle glaucoma and ocular
hypertension: a longitudinal study
Maria del Mar Schilt-Catafal, Vicente T. Pérez-Torregrosa, Antonio M. Duch-Samper (Spain)
P2.78 P
igmentary open-angle glaucoma in Leber’s hereditary optic neuropathy: case report
Mariana Portela, Marta Correia, Margarida Baptista, João Costa, Maria Patricio (Portugal)
P2.79 A b-interno canaloplasty standalone versus combined with cataract surgery - 36-month outcomes in
Poster Sessions
1000+ eyes
Mahmoud Khaimi (USA)
P2.80 Plasma rich in growth factors as an adjuvant agent in non-penetrating deep sclerectomy
Pedro Pablo Rodriguez-Calvo, Ignacio Rodriguez-Una, Montserrat García, Hector Gonzalez-Iglesias,
Andres Fernandez-Vega-Cueto, Jesus Merayo-Lloves (Spain)
36
P2.81 Intra-ocular pressure response to dexamethasone implant injections in patients with a history of filtering
surgery: the TRABEX study
Amina Rezkallah, Philippe Denis, Kodjikian Laurent, Mathis Thibaud (France)
P2.82 C hanging prevalence of glaucoma-related vision loss in Europe over the last 20 years: findings from the
Global Vision Database of the Vision Loss Expert Group
Rupert Bourne1, Jost Jonas2, Alain Bron3, Jaimie Steinmetz4, Paul Briant4, Tabassom Sedighi1,
Nicolas Leveziel3, Maria Cicinelli5, Luca Rossetti5, Ian Tapply1, Serge Resnikoff6, Theo Vos4, Hugh
Taylor6 (1United Kingdom, 2Germany, 3France, 4USA, 5Italy, 6Australia)
P2.83 G
laucoma conversion of the contralateral eye in unilateral normal-tension glaucoma patients: a 5-year
follow-up study
Jin-Soo Kim, Hyuk Jin Choi, Ki Ho Park (South Korea)
P2.84 Intraocular pressure fluctuation and rates of visual field progression in primary open-angle glaucoma: an
exploratory analysis from the United Kingdom Glaucoma Treatment Study (UKGTS)
Alessandro Rabiolo, Giovanni Montesano, David Crabb, David Garway-Heath (United Kingdom)
Poster Sessions
37
10:40
COVID-related clinical experience | Genetics | Treatment - Surgery/Laser
Moderators: Mario Economou (Switzerland), Stylianos Georgoulas (United Kingdom),

P3.01 A
genome-wide association study for a corticosteroid-induced increase in intraocular pressure after using
topical corticosteroids
Ilona Liesenborghs, van Beek Daan, Adriaens Michiel, Tos Berendschot, Theo Gorgels, Iris Boesten,
Michiel Cornelissen, Wishal Ramdas, Rudy Nuijts, Henny Beckers, Carroll Webers, Lars Eijssen, Jan
Schouten (The Netherlands)
P3.02 O
cular severe involvement in oculofaciocardiodental syndrome: description of a case series
Ana Filipa Moleiro, Joana Santos Oliveira, Augusto Magalhães, Pedro Alves Faria, Fernando Falcão-
Reis, Sérgio Estrela Silva (Portugal)
P3.03 G
enetics of congenital glaucoma in 31 Bulgarian patients
Neda Sergeeva, Stanislava Kostova, Kunka Kamenarova, Nevyana Veleva, Alexander Oscar
(Bulgaria)
P3.04 A
xenfeld-Rieger syndrome associated glaucoma
Yoanna Kaneva, Nevyana Veleva, Alexander Oscar (Bulgaria)
P3.05 M
YOC gene mutation associated POAG: a study in two families of Czech origin
Andrea Vergaro, Marek Fichtl, Lucie Rezková, Jana Jedlicková, Lubica Dudakova, Petra Lišková
(Czech Republic)
P3.06 R
etrospective analysis of telematic glaucoma clinic as a consequence of COVID-19 pandemic
Pau Romera Romero, Adrián Sánchez-Fortún Sánchez, Jéssica Botella García, Andres Fernandez-
Vega-Cueto, Jordi Loscos Arenas (Spain)
P3.07 R
emote glaucoma patients postoperative follow-up using mobile gadgets
Galina Vashkevich (Belarus)
P3.08 O
ptic nerve head changes measured with optical coherence tomography angiography in COVID-19
patients one year after infection
Beatriz Rodriguez Aguado, Elizabeth Salcedo Mafla, Bárbara Delás Alos, Mamen Carmona Orozco
Mouafk Asaad (Spain)
P3.09 E ffect of the COVID-19 pandemic on progression to glaucoma surgery in patients followed up in a retina
unit
Mustafa Kalayci, Birumut Gedik, Elcin Suren, Muhammet Kazim Erol (Turkey)
P3.10 P
eripheral laser iridoplasty in chronic narrow-angle glaucoma: anatomical results examined by sd
anterior segment OCT
P3.11 D
ifference in safety profile and intraocular pressure (IOP) changes during Ziemer LDV Z8 femtosecond
laser pretreatment of cataract between eyes with primary angle closure disease and normal eyes
ZhuLi Yap, Wesley Chong, Tina Tzee Ling Wong (Singapore)
P3.12 S urgical management of primary angle-closure glaucoma

Poster Sessions
Juan Carlos Izquierdo Villavicencio, Ariadne Cortes, Marta Hadid Dra, Mirel Rincon Sanchez (Peru)
P3.13 L aser iridotomy versus combined phacoemulsification and viscogonioplasy in treatment naïve primary
angle closure patients: results from a tertiary centre in the UK
Suresh Thulasidharan, Aby Jacob, Francesco Stringa (United Kingdom)
38
P3.14 R
esults after treatment with MicroShunt Preserflo® of refractory to medical treatment congenital
glaucoma in a patient with mycosis fungoides included in clinical trial ASTX660
Marta Fernandez, Laura Guerrero, Irene Platas, Jacobo Herrera, Pedro Salva (Spain)
P3.15 E valuation of risk factors for failure in primary congenital glaucoma patients with 360 degree Ab externo
suture trabeculotomy
Serhat Imamoglu, Yucel Ozturk, Süleyman Kugu (Turkey)
P3.16 C hallenges in artificial drainage system implantation in pediatric advanced secondary glaucoma
Anca Pantalon, Crenguta Feraru, Marius Giurgica, Dorin Chiselita (Romania)
P3.17 L ong term outcomes of primary deep sclerectomy in primary congenital glaucoma
Abdullah Bin Hemid, Ibrahim Aljadaan, Konrad Schargel, Adi Al Owaifeer, Ibrahim Al Obaida, Syed
Khabir Ahmad, Mohanad Al Jetaily, Dr Eman AlHussain (Saudi Arabia)
P3.18 Effectiveness and safety of the gel stent versus trabeculectomy in patients with primary open angle
glaucoma: a 12-month randomized, multicenter study
Inder Singh1, Vanessa Vera2, Arhsam Sheybani2, Gagan Sawhney2, Xuemin Gu2, Mark Gallardo2
(1USA, 2Venezuela)
P3.19 Surgical outcome comparison between initial trabeculectomy and Ex-Press in terms of achieving an
intraocular pressure of < 15 and 18 mmHg: a retrospective single center comparative study
Shunsuke Nakakura, Ryo Asaoka (Japan)
P3.20 E ight-year outcomes of two first-generation trabecular micro-bypass stents (iStent) with
phacoemulsification in primary open-angle glaucoma
Ali Salimi, Harrison Watt, Paul Harasymowycz (Canada)
P3.21 T he LiGHT trial 6-year follow-up results

Gus Gazzard1, Evgenia Konstantakopoulou1,2, Mariam Adelenke1, Gareth Ambler1, David Garway-
Heath1, Victoria Vickerstaff1, Neil Nathwani1 (1United Kingdom, 2Greece)
P3.23 Corneal endothelial cell loss after phacoemulsification and YAG-laser activation of trabecula in primary
open-angle glaucoma and co-existing cataract
Tatiana Sokolovskaya, Valeriya Gutnik (Russian Federation)
P3.24 S urgical outcomes of Xen45 gel stent implantation with the open conjunctiva approach in patients with
primary open-angle glaucoma: a retrospective comparative study
Sangwoo Moon, Jiwoong Lee (South Korea)
P3.25 M
inimally invasive glaucoma surgery with three generations trabecular micro-bypass implants in
combination with cataract surgery for glaucoma: results after 1 year
Henny Beckers, Lotte M.J. Scheres, Ronald de Crom (The Netherlands)
P3.26 Intraoperative use of free conjunctival autograft in trabeculectomy due to acute conjunctival contraction
Dimitrios Alonistiotis, Antonios Manolakis, Dimitra Oikonomou, Petko Hristov, Panagiotis
Theodossiadis (Greece)
P3.27 T he long term effect of ciliary body diode (cyclodiode) ablation on visual acuity in glaucoma patients
Jack West, Abhay Ghaiwal, Wai Siene Ng (United Kingdom)
P3.28 C ombined excimer laser trabeculostomy and phacoemulsification: three-year follow-up of intraocular
pressure-lowering effect and endothelial cell loss
Eva Gonzalez Aquino, Antonio Moreno Valladares, Teresa Prieto Moran, Nieves Puerto Amorós,
Francisca Gonzalez López, Mónica Martínez Díaz (Spain)
P3.29 S afety and efficacy of PreserFlo MicroShunt in refractory glaucoma, a one year study
Antoine Labbe, Alexandre Majoulet, Pascale Hamard, Emmanuelle Brasnu-De Cenival, Christophe
Poster Sessions
Baudouin (France)
P3.30 E ffectiveness and safety of the XEN 45 Gel Stent as a minimally invasive glaucoma surgery device in the
management of open-angle glaucoma
Simon Neary, Edward Dervan (Ireland)
39
P3.31 G
oniotome I/A in the treatment of primary open-angle glaucoma
Antonios Manolakis, Dimitra Oikonomou, Maria Kouvari, Aggeliki Androu, Petko Hristov, Dimitrios
Alonistiotis (Greece)
P3.32 H
ydrus microstent for patients with primary open-angle glaucoma combined with cataract surgery:
primary results from a retrospective case series in England
Mohamed Elghobaier, Georgios Chatzithanasis, Symeon Nicolaou, Yunfei Yang, Mahmoud
Radwan, Achyut Mukherjee, Chrysostomos Dimitriou (United Kingdom)
P3.33 E fficacy and safety of phacoemulsification associated with iStent Inject W® in patients with controlled
open-angle glaucoma
Yanis Louanchi, Emmanuelle Brasnu-De Cenival, Pascale Hamard, Vittoria Aragno, Christophe
Baudouin, Antoine Labbe (France)
P3.34 A
prospective, 24-month evaluation of subjects with mild to moderate open-angle-glaucoma treated
with the OMNI® surgical system as standalone procedure
Karsten Klabe, Andreas Fricke (Germany)
P3.35 P
reserFlo MicroShunt - the better trabeculectomy? Our long-term results with the microshunt in surgical
glaucoma therapy
Jan Philipp Werth, Andreas Fricke, Karsten Klabe (Germany)
P3.36 5
years-results of combined cataract surgery with iStent Inject W® in patients with cataract and open
angle glaucoma
Hakan Kaymak, Andreas Fricke, Karsten Klabe (Germany)
P3.37 L ong-term survival analysis of the effectiveness of PreserFlo MicroShunt in open-angle glaucoma
patients
Cristina Ginés Gallego, Antonio Pascual-Santiago, Jacobo E. Enríquez-Fuentes, Jose Martinez-de-la-
Casa, Julian Garcia Feijoo (Spain)
P3.38 D
ual blade goniotomy in addition to usual fenestrating slits to enhance early intraocular pressure
lowering in non-valved aqueous shunt surgery for primary open angle glaucoma
Mary Qiu, Saira Khanna, June Si, Christos Theophanous (USA)
P3.39 E ffect of Kahook Dual Blade (KDB) ab-interno trabeculectomy on tonographic outflow facility compared
to iStent Inject
Thomas Sherman, Anindyt Nagar, Saurabh Goyal, Emily Dowse, Elizabeth Galvis, Andrew Amon,
Shireen Ognjenovic, Pouya Alaghband, Sheng Lim (United Kingdom)
P3.40 3
-year outcomes of excisional goniotomy with the Kahook Dual Blade for glaucoma in Bolivia
Manuel Justiniano (Bolivia)
P3.41 E ffects of socioeconomic status on baseline values and outcomes at 24 months in the treatment of
advanced glaucoma study (TAGS)
Anthony King, Jemma Hudson, Augusto Azuara-Blanco, James Kirwan, K. Sheng Lim, Saurabh
Goyal, Graeme MaClennan (United Kingdom)
P3.42 E arly results of irrigating goniectomy with TrabEx+: a novel device for the treatment of open-angle
glaucoma
Haoyu Wang, Daniel Gosling, Graham Auger (United Kingdom)
P3.43 D
ouble is better than one
Mauro Fioretto, Matteo Orione, Andrea Grosso (Italy)
P3.44 W
ill the PreserFlo™ MicroShunt replace trabeculectomies? Results of a UK and Éire Glaucoma Society
(UKEGS) Survey
Matthew Kuet, Anthony King, Augusto Azuara-Blanco, Keith Barton (United Kingdom)
Poster Sessions
40
P3.45 T rabecular microbypass iStent Inject W implantation combined with cataract surgery in open-angle
glaucoma eyes - 12-month outcomes
Ismael Bakkali El Bakkali, Elena Pardina, Ana Boned-Murillo, Pablo Cisneros, Eva Josefina Núñez
Moscarda, José Ignacio Sánchez Marín, Itziar Pérez, Juana Martinez, Juan Ibañez (Spain)
P3.46 C analoplasty and trabeculotomy with the OMNI system in pseudophakic patients with open-angle
glaucoma: the ROMEO II study
Jaime Dickerson, Kavita Dhamdhere, Daniel Terveen (USA)
P3.47 T rabeculectomy versus the PreserFlo MicroShunt: a comparison of their efficacy and safety at
Addenbrooke’s Hospital, Cambridge University Hospitals (CUH) NHS Foundation Trust
Disha Singhania, Tasneem Khatib, Geoffrey Chan, John Britton, Stylianos Georgoulas, Fiona Lim,
Sherif Mohamed, Humma Shahid, Ian Tapply, Rupert Bourne (United Kingdom)
P3.48 C hanges in corneal endothelial cell density after aqueous shunt surgery and trabeculectomy in patients
of Black African or African-Caribbean origin: 1 year follow-up
Andrew Swampillai, Pirro Hysi, Irfan Versi, Anindyt Nagar, Emily Dowse, Andrew Amon, Elizabeth
Galvis, Sheng Lim (United Kingdom)
P3.49 T rabeculectomy versus XEN gel implant for the treatment of open-angle glaucoma: a 4-year
retrospective analysis
Ilaria Di Mola, Francesca Cappelli, Carlo Alberto Cutolo, Chiara Pizzorno, Carlo E. Traverso (Italy)
P3.50 M
icropulse laser trabeculoplasty (MLT): a promising treatment for open angle glaucoma
Eirini-Christina Christodoulaki, Athina Athanasiou, Konstantina Mouriki, Dimitra Kavroulaki,
Michael Zentelis (Greece)
P3.51 S urgical outcomes of ab interno viscocanaloplasty (ABIC) combined with cataract surgery in open-angle
glaucoma: 36-month results
Kevin Gillmann1, Jean-Marc Baumgartner2, Laëtitia Niegowski2 (1United Kingdom, 2Switzerland)
P3.52 X
EN-augmented deep sclerectomy: surgical outcomes and comparison with non-penetrating deep
sclerectomy at 6 months
Kevin Gillmann1,2, Jean-Marc Baumgartner2, Laëtitia Niegowski2 (1United Kingdom, 2Switzerland)
P3.53 8
-year follow-up of excimer laser trabeculostomy (ELT): clinical outcomes
Michael S. Berlin, Ryan Lamrani, Anne Nguyen, Rebecca Doan, Emily Chen, Brian Simon, Jonathan
Shakibkhou, Sylvia Groth (USA)
P3.54 C horoidal effusion and hypotony maculopathy after PreserFlo MicroShunt

Irena Serov-Volach, Chris Panos (United Kingdom)
P3.55 S hallow anterior chamber as a complication after trabeculectomy in a patient with primary open angle
glaucoma and chronic anterior uveitis
Kristina Belcheva (Bulgaria)
P3.56 S urgical outcomes of Schlemm’s canal peeling in eyes with open-angle glaucoma
Alev Ozcelik Kose, Raziye Donmez Gun, Serhat Imamoglu, Süleyman Kugu (Turkey)
P3.57 L ong term survival of filtering bleb after trabeculectomy surgery in cataract patients
Aliki Liaska (Greece)
P3.58 E fficacy of phacoemulsification and phacoemulsification in combination with goniosynechiolysis in the

surgical treatment of chronic angle-closure glaucoma: 2-years study
Ihor Novytskyy, Rostyslav M. Lopadchak (Ukraine)
P3.59 L ong-term effectiveness and safety of early lensectomy in patients with pseudoexfoliation
Ignacio Rodriguez-Una, Pedro Pablo Rodriguez-Calvo, Montserrat García, Andres Fernandez-Vega-
Poster Sessions
Cueto, José Alfonso (Spain)
P3.60 M
icropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with glaucoma and ocular cicatricial
pemphigoid
Celina Logioco, Noelia Podesta, Leila Galetto, Azul Rodriguez Libarona, Florencia Valvecchia,
Virginia Zanutigh (Argentina)
41
P3.61 P
reserFlo MicroShunt for secondary glaucoma in patients with hereditary transthyretin amyloidosis:
initial results
ElodieDa Cunha, EmmanuelBarreau, JérômeJoffre, Pierre-EmmanuelRemongin, NicolasMesplié,
Marc Labetoulle, Antoine Rousseau (France)
P3.62 P
reserFlo MicroShunt® implanted in a patient with a bilateral scleromalacia perforans
Adrián Sánchez-Fortún Sánchez, Pau Romera Romero, Jéssica Botella García, Marta Balboa, Jordi
Loscos Arenas (Spain)
P3.63 F rom one tube to another. Exchanging an Ahmed valve for a Baerveldt shunt in a secondary glaucoma
Chryssa Terzidou, Alexandra Trivli, Georgios Dalianis (Greece)
P3.64 N
on-penetrating deep sclerectomy with Nd:YAG laser goniopuncture versus trabeculectomy in patients
with secondary glaucoma after silicone oil removal
Maryna Karliychuk, Serhii Pinchuk (Ukraine)
P3.65 P
rompt primary cyclophotocoagulation with subsequent aqueous shunt as needed for neovascular
glaucoma with synechial angle closure
Jessie Wang, Mary Qiu (USA)
P3.66 C linical outcomes of Ahmed glaucoma valve implantation in secondary glaucomas at Hospital Pedro
Hispano
Rita Basto, Renato Barbosa, Rita Viana, Alexandre Silva, Carolina Vale, Rita Gonçalves, Ricardo
Bastos, Paula Tenedório (Portugal)
P3.67 T he management of uveitic glaucoma with PAUL® glaucoma implant

Filofteia Tacea, Neeru Vallabh, Kenneth Yau, Cecilia Fenerty, Fiona Spencer, Leon Au (United
Kingdom)
P3.68 F easibility, efficacy and safety of early lens extraction in patients with pseudoexfoliation glaucoma: a
feasibility and pilot study
Sara Pose-Bazarra1, Maria Jesus Lopez-Valladares1, Ignacio López-de-Ullibarri1, Augusto Azuara-
Blanco2 (1 Spain, 2United Kingdom)
P3.69 M
ethods for treatment of secondary uncompensated glaucoma
Begimai Kasygulova, Tatiana Lubimova (Russian Federation)
P3.70 C hanges in anterior segment parameters after phacoemulsification in patients with pseudoexfoliation
glaucoma versus patients with primary open-angle glaucoma and normal subjects
Hatice Tekcan, Serhat Imamoglu, Süleyman Kugu (Turkey)
P3.71 C hallenges in combined Ahmed valve and phacoemulsification with intraocular lens implantation in
secondary glaucoma
Dorin Chiselita, Madalina Balha, Anca Pantalon (Romania)
P3.72 G
laucoma surgery in secondary uveitic glaucoma in children with juvenile idiopathic arthritis
Eva Skrla, Otakar Dušek, Petra Svozilkova, Jarmila Heissigerova, Marek Fichtl (Czech Republic)
P3.74 Combined Ahmed valve/gonioscopy-assisted transluminal trabeculotomy: a novel surgical technique for
advanced open angle glaucoma
William Trask, Ammar Khan, Andrew Crichton (Canada)
Poster Sessions
42
16:45
Treatment - Surgery/Laser
Moderators: Delphine Bifrare (Switzerland), Maria Da-Luz Freitas (Portugal), Stylianos Kandarakis (Greece)
CT-A analysis of filtration bleb vascularization after Santen PreserFlo Microshunt implantation
P4.01 O
Martin Kallab, Sophie Beka, Anna Reisinger, Matthias Bolz, Clemens Strohmaier (Austria)
P4.02 Non-penetrating deep sclerectomy versus standalone XEN gel stent: a retrospective comparative study
Arnaud Touboul, Yves Lachkar (France)
P4.03 L ong-term outcomes of micropulse transscleral cyclophotocoagulation in a tertiary hospital

Júlio Almeida, Maria Teixeira Dias, Catarina Monteiro, Rita Basto, Ana Sofia Lopes, Fernando Vaz,
Isabel Prieto (Portugal)
P4.04 T rabeculectomy surgical skill training program aimed at 3rd year residents and fellows, performed at
Hospital Italiano de Buenos Aires, on animal eye models
Arturo Burchakchi, Agustina de Gainza, Franco Hernandez (Argentina)
P4.05 T he Moorfields safer surgery system trabeculectomy surgical outcomes: a 10-year retrospective study
Catarina Monteiro, Júlio Almeida, Joana Roque, Mário Ramalho, Ana Sofia Lopes, Fernando Vaz,
Isabel Prieto (Portugal)
P4.06 P
ostoperative assessment following iStent Inject W implant with NIDEK GS-1 automated gonioscopy
Irena Serov-Volach, Bhagyashree Joshi, Aby Jacob, Francesco Stringa (United Kingdom)
P4.07 S mart app to predict best personalized minimally invasive glaucoma treatment (iMIGS)
Umair Qidwai, Uvais Qidwai, Gokulan Ratnarajan (Qatar)
P4.08 T he effect of different post-selective laser trabeculoplasty treatment modalities on intra-ocular pressure
reduction
Ahmed Wanas, Max Davidson, Simon Ruben (United Kingdom)
P4.09 A
retrospective review of PreserFlo MicroShunt surgery at a single surgical centre in England
Symeon Nicolaou, Chrysostomos Dimitriou, Achyut Mukherjee, Mahmoud Radwan, Georgios
Chatzithanasis, Mohamed Elghobaier, Yunfei Yang, Asad Zaheer (United Kingdom)
P4.10 Intermediate-term outcomes of combined phacoemulsification with ab interno excisional goniotomy

with the Kahook Dual Blade
Theodoros Filippopoulos1, Dimitrios Tsoukanas1, Sotiria Palioura2, Dimitra Kopsini1, Gerasimos
Kopsinis1 (1Greece, 2USA)
P4.11 S elective laser trabeculoplasty (SLT) as an adjunct therapy in advanced pseudoexfoliative glaucoma and
advanced primary open angle glaucoma
Inbar Gur, Eran Berkowitz, Maroun Khreish, Islam Al-Hashash, Avi Schwalb, Inbar Waizer, Beatrice
Tiosano (Israel)
P4.12 G
oniotomy with Kahook Dual Blade in medically uncontrolled glaucoma
Anna Barkander, Gauti Jóhannesson, Mario Economou (Sweden)
P4.13 S hort term safety and efficacy of the PreserFlo MicroShunt in high risk glaucoma patients who have
Poster Sessions
undergone conjunctival scarring procedures including: trabeculectomy, tube surgery and diodes
Ishani Barai, Ahmed Al-Nahrawy, Sally Ameen, Faisal Ahmed (United Kingdom)
P4.14 E fficacy and safety of combined 27-G vitrectomy and Ahmed valve using same sclerotomy site for the
tube placement: a case series
Francesc Franquesa Garcia, Nestor Ventura Abreu, Joan Giralt, Anna Sala-Puigdollers, Marta Pazos
(Spain)
43
P4.15 T wo-year safety and efficacy results of a supraciliary drainage device in patients with open angle
glaucoma - a meta-analysis from STAR-I, STAR-II and STAR-III trials
Antonio Maria Fea (Italy)
P4.16 D
escemet membrane detachment after non-penetrating deep sclerectomy associated to increased
pressure in the scleral lake
Laia Jaumandreu, Laura Diez Alvarez, Cristina Ye Ye Zhu, Gema Rebolleda Fernández, Francisco
José Muñoz Negrete (Spain)
P4.17 T ransient ciliochoroidal detachment after microhook ab interno trabeculotomy

Kazuyuki Hirooka, Fumiya Miyako, Hiromitsu Onoe, Naoko Okada, Hideaki Okumichi, Yoshiaki
Kiuchi (Japan)
P4.18 U
ltrasound cycloplasty using high-intensity focused ultrasound in open angle glaucoma myopic patients
Michele Figus, Alessandro Palma, Giuseppe Covello, Chiara Posarelli (Pisa)
P4.19 F ive-year results with the PreserFlo™ MicroShunt for surgical treatment of glaucoma
Stefani Kujovic, Lotte M.J. Scheres, Ronald de Crom, Carroll Webers, Henny Beckers (The
Netherlands)
P4.20 E xpert consensus on the use of the PreserFlo™ MicroShunt device in the treatment of glaucoma: a
modified Delphi Panel
Anthony Khawaja1, Ingeborg Stalmans2, Florent Aptel3, Keith Barton1, Henny Beckers4, Thomas
Klink5, Giorgio Marchini6, Jose Martinez-de-la-Casa6, Jan Henrik Simonsen7, Marc Toeteberg-
Harms8,9, Clemens Vass10, Luis Abegão Pinto11 (1United Kingdom, 2Belgium, 3France, 4The Netherlands,
5
Germany, 6Spain, 7Denmark, 8Switzerland, 9USA, 10Austria, 11Portugal)
P4.21 G
LAUrious, a multicentre, randomised, controlled non-inferiority study of direct selective laser
trabeculoplasty in open angle glaucoma
Gus Gazzard, GLAUrious Study Group (United Kingdom)
P4.22 C ombined excimer laser trabeculostomy and phacoemulsification: a multicenter real-word data study
Antonio Moreno Valladares, Ester Roquet, Maribel Canut, Eva Gonzalez Aquino, Nieves Puerto
Amorós, Francisca Gonzalez López, Teresa Prieto Moran, Marta Mármol, Federico Trejos, Francisco
Ruiz Tolosa, Mónica Martínez Díaz (Spain)
P4.23 A
ntimicrobial activity of topical ophthalmic anesthetics and topical ophthalmic antiseptics against
microorganisms, received from the patients prior glaucoma filtrating surgery
Halyna Nazarchuk, Oleksandr Nazarchuk, Uliana Babina (Ukraine)
P4.24 P
ostoperative pain after different transscleral laser cyclophotocoagulation procedures
Thomas Falb, Lukas Hoeflechner, Astrid Heidinger, Fabian Wallisch, Hrvoje Tomašic, Domagoj
Ivastinovic, Ewald Lindner (Austria)
P4.25 Sutureless deep sclerectomy with fibrin sealant (Tisseel) - preliminary outcomes
Alina-Dana Baxant, Lucie Holubova, Patrik Pluhovsky, Pavel Studeny (Czech Republic)
P4.26 T he eyePlate-300 implant: results in refractory glaucoma

Syed Ahmed, Simrun Virdee, Ahmed Al-Nahrawy, Ahmed Mazrouaa, Faisal Ahmed (United
Kingdom)
P4.27 A
nalysis of a series of patients who underwent PAUL glaucoma implant surgery and removal of the tutor
before the third postoperative month
Elena Milla, Francesc Franquesa Garcia, Jordi Izquierdo Serra, Valeria Constanza Opazo Toro (Spain)
P4.28 U
sefulness of guided implantation of Ahmed glaucoma valve
Chang Kyu Lee, Ji Hyoung Chey (South Korea)
Poster Sessions
P4.29 R
eal world efficacy and safety of XEN45 secondary bleb needling
Mordechai Goldberg1,2, Eran Berkowitz1,2, Simon Ruben1 (United Kingdom, 2Israel)
44
P4.30 E valuation of selective laser trabeculoplasty effectiveness in patients with ocular hypertension and open-
angle glaucoma
Dmytro Martynov, Ostap Horobiuk, Vitalina Horobiuk, Oleh Horobiuk (Ukraine)
P4.31 T he management of neovascular glaucoma: a systematic review and meta analysis of randomised
controlled trials
Saajan Ramji, Gurnoor Nagi, Abdus Samad Ansari, Obeda Kailani (United Kingdom)
P4.32 M
icropulse trans-scleral cyclophotocoagulation (MPTCP) versus continuous wave trans-scleral
cyclophotocoagulation (TCP) in eyes with glaucoma - the Diode in Glaucoma Study (DIGS)
Jayant Venkatramani Iyer, Xianhui Lim, Olivia Shimin Huang, Tina Tzee Ling Wong (Singapore)
P4.33 Impact of PreserFlo® MicroShunt on the corneal endothelial cells

Caroline Gassel, Karl Ulrich Bartz-Schmidt, Bogomil Voykov (Germany)
P4.34 R
eoperations for complications after gel stent implantation or trabeculectomy
Carlo Alberto Cutolo, Michele Iester, Ilaria Di Mola, Carlo Catti, Chiara Pizzorno, Chiara Bonzano,
Alessandro Bagnis, Carlo E. Traverso (Genoa)
P4.35 E fficacy and safety of application of MMC 0.4 mg/mL for 5 minutes with PreserFlo MicroShunt
Eamonn Fahy, Anurag Garg, Sheng Lim (United Kingdom)
P4.36 D
ifferences in outcomes of ab externo trabeculectomy performed by residents versus assistants
Mário Lima-Fontes1, Ana Faria-Pereira1, Mariana Leuzinger Dias1, Marta Silva1, João Barbosa
Breda1,2, Joana Rodrigues Araújo1, Sérgio Silva1,3, Antonio Melo1,3, Flávio Alves1, João Tavares-
Ferreira1 (1Portugal, 2Belgium, 3Portugal)
P4.37 M
odified technique of Ex-Press filtration device combined with a scleral pocket for severe open angle
glaucoma: the experience of a tertiary center
Rita Vieira, Miguel Afonso, Ana Figueiredo, Rita Reis, Isabel Sampaio, Maria João Menéres
(Portugal)
P4.38 Intraoperative downsizing of the Baerveldt implant plate in elderly patients with short eyes
Juha Välimäki (Finland)
P4.39 A
simple surgical solution for the treatment of persistent postoperative hypotony after PreserFlo
MicroShunt implantation
Soledad Aguilar Munoa, Yih-Horng Tham, Keith Barton (United Kingdom)
P4.40 D
ilated, atonic pupil after micropulse transscleral laser treatment
Alexander Cunea1,2, Ahmed Al-Nahrawy2,3, Nada Mohamed2, Mahmoud Radwan2, Faisal Ahmed2,
Laura Crawley2, Philip Bloom2 (1Germany, 2United Kingdom, 3Egypt)
P4.41 Is trabeculectomy associated with an improvement in circumpapillary RNFL or macular GCIPL thickness?
Tej Malcolm, Andrew Tatham (United Kingdom)
P4.42 A
hmed clearpath in refractary glaucoma: 2 year follow up of safety and efficacy
Syril Dorairaj, Leticia Checo, Richard Ten Hulzen, Isabella Wagner, Abhimanyu Ahuja, Aarav Patel
(USA)
P4.43 PreserFlo as a rescue surgical technique. Results after six months
Jéssica Botella García, Jordi Loscos Arenas, Pau Romera Romero, Adrián Sánchez-Fortún Sánchez,
Andres Fernandez-Vega-Cueto (Spain)
P4.44 E fficacy and safety of the XEN45 implant at 4 years

Victor Mallén Gracia, Maria Pilar Bambó Rubio, María José Vicente Altabás, Jacobo Yañez Merino,
Alvaro Tello, Andrés Biescas (Spain)
Poster Sessions
P4.45 Intraocular pressure control, bleb morphology and adverse effects after trabeculectomy with adjunctive
use of Mitomycin - C and bevacizumab
Pir Salim Mahar (Pakistan)
45
P4.46 S ystematic review of the method and quality of reporting of complications from studies evaluating
innovative glaucoma surgical procedures
Jonathan Bonnar, Augusto Azuara-Blanco (United Kingdom)
P4.47 IStent Inject: our results

Valeria Opazo Toro, Maria Jesus Muniesa, Georgina Casanovas, Nestor Ventura Abreu, Elena Milla,
Marta Pazos (Spain)
P4.48 H
ydraulic conductivity of the filtering bleb wall with the PreserFlo MicroShunt: objective mathematical
measurement of bleb function
Marta Ibarz Barberá, Jean Bragard, Fatima Martinez Galdon, Jose Luis Hernandez Verdejo, laura
Morales Fernández, Pedro Tañá Rivero, Miguel Teus Guezala (Spain)
P4.49 Is direct anaesthetic support needed for all Baervelt tube surgery?
Yingjia Yang, James Kirwan (United Kingdom)
P4.50 L ong term effects of trabeculectomy on visual field progression across two centres in the United
Kingdom: a 10 year follow up
Yingjia Yang, Matthew Shah, Hannaa Bobat, Anastasios Sepetis, Peter Shah, James Kirwan (United
Kingdom)
P4.52 S urgical outcome of Molteno3 in uncontrolled glaucoma
Carlos A. Arciniegas-Perasso, Susana Duch, Osvaldo Guevara-Chavarría (Spain)
P4.53 1
0+ year clinical outcomes of tube shunt surgery on glaucomatous patients
Ryan Lamrani, Jae Chiang Wong, Daniel Lee, Jonathan S. Myers (USA)
P4.54 E fficacy and safety of a novel Ahmed valve implantation technique: a 5-year retrospective study
Stefano Gandolfi, Luigi Varano, Nicola Ungaro, Paolo Mora, Viola Tagliavini, Salvatore Tedesco
(Italy)
P4.55 T rabeculectomy vs non-penetrating deep sclerectomy for the surgical treatment of open-angle
glaucoma: a long-term report of 201 eyes
Renato Barbosa, Rita Gonçalves, Ricardo Bastos, Sara Pereira, Rita Basto, Rita Viana, Paula
Tenedório (Portugal)
P4.56 X
EN in the management of early glaucoma surgery: a national Delphi consensus study
Jose Martinez-de-la-Casa, Jose Manuel Larrosa, Rafael Gimenez, Francisco Javier Goñi, Elena Milla,
Marta Pazos, Susana Perucho Martinez, J. Aritz Urcola (Spain)
P4.57 T rab vs PhacoTrab: is a bird in the hand better than two in the bush?
Francisco Alves, Júlio Brissos, Guilherme Almeida, Miguel Leitão, Catarina Rodrigues, Manuel
Marques, Carlos Perpétua, Joana Valadares, Jorge Godinho, José Fernandes, João Segurado
(Portugal)
P4.58 M
icro-pulse cyclophotocoagulation in the treatment of various types of refractory glaucoma
Igor Shiryaev, Marina Pravosudova (Russian Federation)
P4.59 T he expansion of the criteria for Ahmed glaucoma valve implantation

Evgeniya Oblovatskaya, Vadim Nikolaenko (Russian Federation)
P4.60 P
reliminary results of a new technique for ab externo implantation of the XEN gel stent performed at the
slit lamp (SLX)
Nima Shahi (Canada)
P4.61 S erous choroid detachment after glaucoma filtering surgery: series of 23 eyes
Fernando Trejo, Francesc Xavier Garrell, Marta Castany, Jaume Rigo, Antoni Dou (Spain)
Poster Sessions
P4.62 U
se of ologen implant in glaucoma filtration surgeries: a six-months follow up
Stefany Montoya Ortega, Cristina Castella Capsir, Manuel Alexander Castro Diaz, Beatriz Torrellas
Darvas (Spain)
P4.63 O
utcomes of eyeWatch valve implantation for refractory glaucoma
Segolene Roemer, André Mermoud (Switzerland)
46
P4.64 S afety profile and efficacy of trabecular micro-bypass system iStent™ experience from a single centre in
UK
Bhagyashree Joshi, Suresh Thulasidharan, Francesco Stringa, Richard Imonikhe, Nishani
Amerasinghe, Aby Jacob (United Kingdom)
P4.65 Study of the efficacy of selective laser trabeculoplasty in ocular hypertension and glaucoma
Alfonso Rubio Reina, Oier Pérez Díaz, Javier Guzmán, Carlos Lázaro García (Spain)
P4.66 S hort- to medium-term outcomes of Kahook Dual Blade excisional goniotomy with concomitant
phacoemulsification: a pan-Canadian study
Ali Salimi, Lautaro Vera, Rob Pintwala, Oscar Kasner, Marc Mydlarski, Steven Schendel, Dima
Kalache, Paul Harasymowycz (Canada)
P4.67 E fficacy of micropulse laser trabeculoplasty in Asian patients: results at 6-9 months
Michele Pei Wen Leong, Seng Kheong Fang, Eng Hui Gan, Wen Wei (David) Woo (Malaysia)
P4.68 E fficacy and outcomes of Nd:YAG laser goniopuncture after nonpenetrating deep sclerectomy
Ana Vale, Rita Gonçalves, Ricardo Bastos, Renato Barbosa, Rita Basto, Paula Tenedório (Portugal)
P4.69 O
utcomes of filtering surgery with collagen matrix implant (Ologen®) and mitomycin C (MMC) versus
MMC alone
Maria Jesus Muniesa, Valeria Opazo Toro, Marta Pazos, Elena Milla, Nestor Ventura Abreu (Spain)
P4.71 X
EN ab externo and ab interno: comparison of safety and efficacy between both approaches
Yann Bertolani, Marta Castany Aregall, Natalia Anglada, Julia Angrill, Liliana Gutuleac (Spain)
P4.72 L ong term surgical results of nonpenetrating deep sclerectomy using the Ologen implant vs. the Esnoper
V2000 implant
Xavier Garrell Salat, Jaume Rigo, David Aragón Roca, Sandra Banderas García, Fernando Trejo,
Marta Castany (Spain)
P4.73 Intraocular pressure outcomes and failure risk factors of non penetrating deep sclerectomy: the AGORA
registry study
Cédric Schweitzer, Melanie Le Goff, Cindya Achoun, Ewen Le-Quilliec, Charlotte Kalisky, Emilie
Tournaire-Marques (France)
P4.74 P
rospective evaluation of micropulse diode transscleral cyclophotocoagulation in uncontrolled glaucoma
patients: a case series
Marta Garrido Marín, Laura Sánchez Vela, Rafael Fischer, Alejandro Pardo Aranda, Jaume Rigo,
Manuel Antonio Amilburu Pérez, Antoni Dou, Marta Castany, Olivia Pujol Carreras (Spain)
P4.75 R
egistry study of two trabecular micro-bypass iStents© implantation combined with cataract surgery in
various glaucoma types and severities: long-term real-life outcomes
Assoun Marine, Audrey Cougnard-Gregoire, Charlotte Kalisky, Emilie Tournaire-Marques, Melanie
Le Goff, Cédric Schweitzer (France)
P4.76 C hoice of anaesthetic technique for trabeculectomy surgery and analysis of post-operative outcomes
Priyanka Asodaria, Jia Ng, Gerassimos Lascaratos, Sameer Trikha, Avi Kulkarni (United Kingdom)
P4.77 E ffect of the Prolene stent suture on the Baerveldt tube tip position
Chandni Nigam, Jia Ng, Lauren Van Lancker, Sameer Trikha, Avinash Kulkarni, Gerassimos
Lascaratos (United Kingdom)
P4.78 E arly results of PreserFlo microshunt to control intraocular pressure in eyes with previous failed
trabeculectomy
Jia Ng, Gerassimos Lascaratos, Sameer Trikha, Avi Kulkarni (United Kingdom)
P4.79 S urgical outcomes of phacoemulsification combined with iStent considering ethnic background, at a
Poster Sessions
tertiary referral hospital

Hannah Degg, Amruni Choudhari, Jia Ng, Garth Johnston, Nikistratos Yfantis, Gerassimos
Lascaratos, Sameer Trikha, Avi Kulkarni (United Kingdom)
47
P4.80 F ive-year outcomes of XEN gel stent surgery in patients with open-angle glaucoma
Julien Torbey, Giorgio Enrico Bravetti, Harsha L. Rao, Kevin Gillmann, Archibald Paillard, Enrico
Meduri, André Mermoud, Kaweh Mansouri (Switzerland)
P4.81 A
biomaterial drug-eluting device for reducing post-trabeculectomy inflammation and fibrosis
Mark Lemoine, Nina Pohler, Zulal Demir, Colm O’Brien, Fergal O’Brien, Alan Hibbitts (Ireland)
P4.82 M
agnetic resonance imaging of glaucoma drainage devices
Rafael Correia Barão, David Berhanu, Diogo Bernardo Matos, André Diogo Barata, Rita Sousa, Luis
Abegão Pinto (Portugal)
48

13:00 Parallel Industry Session Glaukos
14:00 Trabecular Micro-Bypass; life in the real world Skalkotas
Henny Beckers
Introduction and welcome (The Netherlands)
Albert S. Khouri
Why is real world data important for glaucoma? (USA)
Sayeh Pourjavan
What is real world data teaching us? (Belgium)
Robert Petrarca
How to use Trabecular Micro-Bypass in the real world? (United Kingdom)
Q&A
Closing
Parallel Industry Session Allergan, an AbbVie Company

13:00 Update on medical and surgical therapies in glaucoma
14:00 - everyday management and the new XEN63® - coming Socrates
soon
Herbert Reitsamer
Welcome and Introduction (Austria)
Andrew Tatham
Current challenges in glaucoma management (United Kingdom)
Micro-incisional glaucoma surgery and Importance of early action in Kaweh Mansouri
glaucoma (Switzerland)
New XEN63 - Changing dimensions in micro-incisional glaucoma Herbert Reitsamer
surgery (Austria)
Herbert Reitsamer
Wrap up and close (Austria)
49
Parallel Industry Session iSTAR Medical

13:00 Back to the Future - Supraciliary MIGS at last?
14:00 Moderator: Antonio Fea (Italy) Hippocrates 4
Karsten Klabe
Hey Doc, do we need another MIGS? (Germany)
Antonio Fea
MINIject® - revisiting the past, or realizing a new future? (Italy)
Chrys Dimitriou
The future is NOW: my clinical experience with MINIject® (United Kingdom)
Karsten Klabe
(Germany)
Discussion
50
Educational Partner Symposium Allergan, an AbbVie

12:50 Company
14:20 Today and tomorrow of glaucoma management Plenary Room
Moderator: Andrew Tatham (United Kingdom)
Andrew Tatham
Welcome (United Kingdom)
Sunday, 5 June 2022

Andrew Tatham
Limitations of drop therapy (United Kingdom)
Anthony Khawaja
SLT in clinical trials and real-world evidence (United Kingdom)
Miriam Kolko
Upcoming sustained-release products (Denmark)
Q&A and discussion
Andrew Tatham
Close (United Kingdom)
Parallel Industry Session Horus Pharma

17:55 The adapted management of glaucoma: expectations
18:55 versus reality Skalkotas
Moderator: Jean-Paul Renard (France)
Introduction Horus Pharma
Monitoring glaucoma progression with OCT alone? Expectations vs Jean-Paul Renard

reality (France)
Peripheral iridotomy for all narrow iridocorneal angle? Expectations vs Francisco Javier Goñi
reality (Spain)
Francisco Muñoz Negrete
SLT as first line treatment for all naïve patients? Expectations vs reality (Spain)
Less invasive surgeries or classic filtration surgery? Expectations vs Alfonso Antón López
reality (Spain)
Christophe Baudouin
BAK or not to BAK: interest for efficacy? Expectations vs reality (France)
Generic and hybrid eyedrops less efficient than original drug? Florent Aptel
Expectations vs reality (France)
Nathalie Collignon
The Belgian and Italian experience of preservative-free latanoprost? (Belgium)
Expectations vs reality
Luca Rossetti
(Italy)
51
Parallel Industry Session Carl Zeiss
17:55 Zeiss glaucoma workflow innovation from diagnostic to
18:55 therapy Hippocrates 1
Panel Discussion Moderator: Gus Gazzard (United Kingdom)
Marta Pazos
Integrated digital workflow in glaucoma - novel methodologies (Spain)
Sunday, 5 June 2022
Value of progression analysis for long term patient management and Maria Pilar Casas de Llera
decision for the timely and appropriate treatment (Spain)
Karsten Klabe
Experience with ZEISS SLT as adjunctive therapy - study results (Germany)
Parallel Industry Session Thea

17:55
18:55 Role of adherence in treatment persistency for glaucoma Hippocrates 4
Moderators: Christophe Baudouin (France), Fotis Topouzis (Greece)
Christophe Baudouin
Inflammation in glaucoma: from the front to the back of the eye (France)
Fotis Topouzis
Diagnosis & treatment of inflammation in glaucoma: what works? (Greece)
Barbara Cvenkel
What to do in glaucoma patient for better adherence (Slovenia)
Florent Aptel
What could be the role of E-health to improve patients adherence? (France)
52
Educational Partner Symposium Alcon

12:30
14:00 Introducing Hydrus Microstent into your clinical practice
® Plenary Room
Moderators: Gus Gazzard (United Kingdom), Brett Trauthen (USA)
Gus Gazzard
Introduction and Opening remarks (United Kingdom)
Gus Gazzard
Hydrus® Microstent outcomes in the 5 year The HORIZON RCT (United Kingdom)
Thomas Klink
Hydrus® Microstent surgical implantation steps (Germany)
Verena Prokosch-Willing
Hydrus® Microstent surgical implantation pearls (Germany)
Monday, 6 June 2022

Educational Partner Symposium Thea
16:40 How can we make a real difference in glaucoma
18:10 management over the long-term Plenary Room
Moderators: Miriam Kolko (Denmark), Carlo E. Traverso (Italy)
Miriam Kolko
BAK & trabeculum (Denmark)
Evaluation of glaucoma or ocular hypertension patients with existing Sonja Jandroković

ocular surface disease (Croatia)
Glaucoma treatment and occurrence of glaucoma surgery: real word Anton Hommer
evidence (Austria)
Keith Barton
When surgery is not enough: what to do? (United Kingdom)
Gus Gazzard
Measuring the unmeasurable? Quality of life in glaucoma patients (United Kingdom)
53
Parallel Industry Session Fidia Farmaceutici
18:15 Beyond IOP control: eye care for the glaucoma patient
19:15 Session organized under the aegis of ESASO Hippocrates 1
Moderators: Michele Iester (Italy), Michele Figus (Italy)
Giuseppe Guarnaccia
Opening (Italy)
Luciano Quaranta
360° glaucoma management: how to improve QOL (Italy)
Efficacy and safety of glaucoma therapy: preservative-free and fixed Stefano Gandolfi
dose combinations (Italy)
Michele Iester
Neuroprotection for glaucoma: is there any evidence? (Italy)
Panel discussion with Q&A

Monday, 6 June 2022
Parallel Industry Session Omikron Italia

Quality of life and neuroprotection in glaucoma:
18:15
new results of an international multicenter randomized
19:15 clinical trial with citicoline oral solution Hippocrates 4
Chair: Fotis Topouzis (Greece)
Moderators: David Garway-Heath (United Kingdom), Luca Rossetti (Italy),
Fotis Topouzis (Greece)
Ingeborg Stalmans
How vision loss affects glaucomatous patients Quality of Life
(Belgium)
Rationale for design a RCT on QoL of glaucomatous patients with Francisco Goñi
citicoline oral solution: multifactorial mechanism of action and clinical (Spain)
evidence
Luca Rossetti
Results of the first RCT on vision related QoL of glaucomatous patients (Italy)
David Garway-Heath
How to develop a neuroprotective drug (United Kingdom)
Closing remarks
54
08:00 Industry Breakfast Session Iridex

08:45 A non-incisional treatment runway with laser for glaucoma Hippocrates 1
Tomas M. Grippo
Introduction (Argentina)
David W. Woo
MicroPulse laser trabeculoplasty (Malaysia)
Ronald De Crom
(The Netherlands)
MicroPulse transscleral laser therapy
Tomas M. Grippo
(Argentina)
Ronald De Crom
Continuous-wave cyclophotocoagulation (The Netherlands)
Questions and answers (round table)
YK
Colors used
Santen Blue Santen Deep Blue Black

CMYK: CMYK: CMYK:
C100, M0, Y0, K0 C100, M80, Y0, K0 C0, M0, Y0, K100
12:30 Educational Partner Symposium Santen

14:00 New perspectives in glaucoma care: time for a change? Plenary Room
Norbert Pfeiffer

B Colors used
Welcome and introduction

(Germany)
RGB: RGB: RGB:
R0, G153, B204 R0, G51, B153 R0, G0, B0
Getting to the heart of glaucoma – what’s happening to the trabecular Kin Sheng Lim
meshwork? (United Kingdom)
Francesco Oddone
NTONE The Rho kinase pathway: A novel therapeutic strategy (Italy)
Colors used

PANTONE PANTONE PANTONE
Panel discussion / debate

Process Blue C 2736 C Black C
Taking a step forward: New insights and expert consensus on managing Anthony Khawaja
a complex conundrum (United Kingdom)
Henny Beckers
Sharing clinical experience (The Netherlands)
Panel discussion / Q&A
Norbert Pfeiffer
Summary and close (Germany)
55
The European Glaucoma Society wishes to thank
Educational Partners
CMYK
Colors used

CMYK: CMYK: CMYK:
C100, M0, Y0, K0 C100, M80, Y0, K0 C0, M0, Y0, K100
EGS Congress Supporters
RGB Colors used

RGB: RGB: RGB:
R0, G153, B204 R0, G51, B153 R0, G0, B0
PANTONE Sponsors
Colors used

PANTONE PANTONE PANTONE
Process Blue C 2736 C Black C
56
15th EGS Congress
Athens
4-8 June, 2022
DISCOVER OUR ACTIVITIES

Introducing Hydrus Microstent Into Your ®
Clinical Practice
Room: Auditorium
Moderators: MONDAY
6 JUNE
Gus Gazzard Brett Trauthen
12:30-
14:00
Hydrus® Microstent Outcomes in the
5 year: The HORIZON RCT
Hydrus® Microstent Surgical

Implantation Steps
Thomas Klink (Germany)
Hydrus® Microstent Surgical

Implantation Pearls
Verena Prokosch-Willing (Germany)
Stop by our Booth in Athens

Or explore our Virtual Booth! CONNECT
WITH US!
PAID CONSULTANTS BY ALCON
© 2022 Alcon Inc. 04/22 EMEA-GLA-2200003 57

Today and tomorrow of glaucoma
management
Sunday 5th June 2022 | 12:50-14:20 Athens time
Plenary Room, Megaron Athens International Conference Centre
Join us for this exciting live symposium at EGS 2022

Agenda:
Time
Topic Presenter
(Athens time)
12:50 Distribution of lunch boxes
13:20 Welcome Chair: Andrew Tatham
Limitations of drop
13:25 Andrew Tatham
therapy
SLT in clinical trials and

13:40 Anthony Khawaja
real-world evidence
Upcoming sustained-
13:55 Miriam Kolko
release products
14:10 Q&A and discussion Moderator: Andrew Tatham
14:20 Close Andrew Tatham
SLT, selective laser trabeculoplasty. All times shown are local to the event location.
Andrew Tatham, Anthony Khawaja, Miriam Kolko,

Consultant, Princess Associate Professor, UCL Professor in Translational Eye
Alexandra Eye Pavilion NHS Institute of Ophthalmology Research, Department of Drug
Scotland Research Clinician, Honorary Consultant Ophthalmic Design and Pharmacology,
University of Edinburgh, UK Surgeon, Moorfields Eye Hospital University of Copenhagen,
NHS Foundation Trust, UK Copenhagen and Senior
Consultant, Copenhagen
University Hospital,
Rigshospitalet, Glostrup, Denmark
Symposium is restricted to healthcare professionals only. This non promotional medical symposium is organised and funded by Allergan, an AbbVie company.
DYST-AA-00004-E v3.0 Date of preparation: May 2022
TOGETHER WE CAN BE
At Santen, we are ready to challenge the

status quo in ophthalmology and embrace
a new era of change in glaucoma. TUESDAY
Come and join us at our stand, during the EGS Congress from 7 June
4-8 June, and see how we can be Change Makers together. Listen to talks on decision
making and how glaucoma
management is changing
MONDAY MEET THE EXPERT

SUNDAY 6 June Philip Graves
5 June
Learn more about a
Talk to the experts new era of clinical
and see what needs treatment for glaucoma
SATURDAY to change when it
4 June comes to thinking about
glaucoma patients MEET THE EXPERT
Prof. Christophe
Baudouin How does our thinking
MEET THE EXPERT influence treatment choice?
Prof. Gabor Hollo 10:40-11:00
35mm and Over
Meet our DO NOT MISS

PRESERFLO 12:30-14:00
MicroShunt Santen Symposium
Surgical Partners The glaucomatous
trabeculopathy: ‘New perspectives in
and see how glaucoma care:
How to put glaucoma from science to
we’re changing time for a change?’
patients in the centre of clinical practice
expectations in Led by
glaucoma management 10:40-11:10
glaucoma surgery Prof. Norbert Pfeiffer
10:15-10:45
Visit our booth Join our booth for

to sign up Join our booth for a Santen in 10 Join our booth for
for the dry lab a Santen in 10 a Santen in 10
LIVE
LIVE Challenge LIVE
Challenge ...a new gamified Challenge
...a new gamified learning experience ...a new gamified
learning experience 15:15-15:45 learning experience
15:45-16:15 Hosted by
16:50-17:20
Hosted by Prof. Karl Mercieca Hosted by
Prof. Karl Mercieca Prof. Karl Mercieca
Date of preparation: May 2022 GLAU-EMEA-220008

let's
Théa is a profoundly European We constantly reinvest in Théa's two
company whose independence, priority areas of Innovation and
stability and entrepreneurial spirit are Internationalisation, with
safeguarded by the Chibret family, long-term strategy outweighing short-
open
which has been instrumental in the term profit. Our objectives are
field of ophthalmology for over 150 continuity, enhancing long-term
years. This family governance model partnerships and collaborative
focuses on Théa, its employees, research, transmitting our knowledge,
people values and long-term tackling unmet medical needs by
our
development to fulfill our mission: to offering new treatment or patient
be the "Ophthalmology support models.
Specialist". Internationalisation is rooted in our
Pioneer in preservative-free eye care genes: Théa is currently the first
eyes
treatments, our commitment is to independent ophthalmology
provide innovative products and a laboratory in Europe, and aims to
wide range of medicinal products become a world leader in
(service products, daily-use products) terms of export and international
to healthcare providers and patients presence in compliance with the
in all ophthalmological therapeutic culture of each country where it is
classes. present.
LABORATOIRES-THEA.COM
It is this vision that
makes Théa unique.
Laboratoires Théa
12 rue Louis-Blériot, 63000 Clermont-Ferrand
Getty Images
FRANCE
QUALITY OF LIFE
FOR YOUR MILD-TO-MODERATE
GLAUCOMA PATIENTS1-7
WELCOME
Visit our booth

to know more about Glaukos
1. Belda J, Patel V, Aceituno S, Cantu M, Gicquel G, Botteman M, et al. Clinical And Economic Outcomes Of Microinvasive Glaucoma Surgery (MIGS) With Stents In Patients With Mild- To-Moderate Or Refractory Glaucoma In Spain. Value Heal. 2017
Oct 1;20(9):A580. 2. Belda JI, Patel V, Aceituno S, Cantu M, Gicquel G, Botteman MF, Falvey H. Cost-Consequence Analysis of Microinvasive Glaucoma Surgery with Stents in Patients with Mild-to-Moderate or Refractory Glaucoma in Spain. Manuscript
Submitted. 3. Teus M, Belda JI, Lavín C, Soler M, Aceituno S. Análisis de impacto presupuestario de la introducción de iStent inject® para el tratamiento del glaucoma de ángulo abierto en España. Poster presented at XXXIX Jornadas de Economía de la
Salud, Albacete 12-14 June 2019. 4. Tim Jones, Andy Lee, Heather Falvey, Mary Cantu, Keith Barton, MD, Leon Au, MD. A UK Cost Analysis of iStent® in Patients with Open-Angle Glaucoma from an NHS Commission Perspective. Poster presentation by
Leon Au. ICGS, Montreal 6-8 Sept 2018. 5. Voskanyan L, García-Feijoó J, Belda JI, Fea A, Jünemann A, Baudouin C. Prospective, unmasked evaluation of the iStent inject® system for open-angle glaucoma: Synergy trial. Adv Ther. 2014;31(2):189–201.
6. Buchholz PM, Buchholz A, Bluemle S, Falvey H, Steeds C. Budget impact analysis of trabecular bypass stenting versus trabeculectomy for the treatment of open-angle glaucoma from a German payer perspective. Poster presented at ARVO Feb 2019.
7. iStent inject® Trabecular Micro-Bypass System: Directions for Use, Part #45-0176.
Glaukos is registered trademarks

of Glaukos Corporation.
All rights reserved. ©2022
PM-EU-0194
Breakfast Symposium at EGS 2022
A non-incisional
treatment runway with
laser for glaucoma
Tuesday, June 7th from 8:00 to 8:45 am • Room Hippocrates 1
Dr. Tomas M. Grippo Dr. Ronald De Crom Dr. David W. Woo

Argentina The Netherlands Malaysia
Join us to learn from three glaucoma experts how they are using three laser-based
procedures - MicroPulse® Laser Trabeculoplasty, MicroPulse® Transscleral Laser
Therapy, and Continuous-Wave TSCPC - to treat a wide range of glaucoma types and
severities. They will share recommendations for dosing, optimization, patient selection,
anesthesia, surgical technique, treatment enhancements, settings adjustment,
complications, post-op care, outcomes, and durability. Scan the QR code or visit us at
booth #15 to learn more.
glaucoma@iridex.com • iridex.com/egs
© 2022 Iridex. All rights reserved. AD0224 05.2022
15th EGS Congress
Omikron Italia Monday 6th June

h 6:15 - 7:15 p.m.
Industry Symposium Room Hippocrates 4
Quality of Life and Neuroprotection in Glaucoma:

New Results of an International Multicenter Randomized
Clinical Trial with Citicoline oral solution
Chairmen: D. Garway-Heath, L. Rossetti, F. Topouzis

How vision loss affects glaucomatous patients Quality of Life - I. Stalmans
(Belgium)
Rationale for design a RCT on QoL of glaucomatous patients with Citicoline
oral solution: multifactorial mechanism of action and clinical evidence -
F.J. Goñi (Spain)
Results of the first RCT on vision related QoL of glaucomatous patients - At the end of the Symposium only
L. Rossetti (Italy) the participants will receive the book
“The Beautiful Brain”
How to develop a Neuroprotective drug - D. Garway-Heath (UK)
written by the Nobel prize winner
Closing remarks Santiago Ramón y Cajal
An Evidence Based Company

iSTAR Medical EGS Symposium
Back to the Future – Supraciliary MIGS at last?
DATE: Saturday 4th June LOCATION: Room Hippocrates 4

TIME: 13:00 - 14:00 CHAIR: Antonio Fea (IT)
Speakers:
Karsten Klabe (DE) Antonio Fea (IT) Chrys Dimitriou (UK)
Agenda:
1. Hey Doc, do we need 2. MINIject® – revisiting 3. The future is NOW:

another MIGS? the past, or realizing a my clinical experience
K. Klabe
new future? with MINIject®
(15 minutes) A. Fea C. Dimitriou, K. Klabe
(15 minutes) (20 minutes)
Bio-integrating, supraciliary MIGS

For safe, meaningful and sustained IOP reduction
www.istar-medical.com
The Global
Glaucoma Network
BECOME PART OF IT NOW!
Follow us:
Check out our online resources!

Stay on top of your practice by brushing up on your glaucoma
knowledge with the WGA online resources, available through the
WGA#One portal www.wga.one/dashboard.
What you will find:
o Journal of Glaucoma o Video Library

o International Glaucoma Review o Online Courses
o Webinars o Fellowship Program
www.worldglaucoma.org
THE #1
MIGS COMPANY
WORLDWIDE*
WELCOME
Visit our booth

to know more about Glaukos
*Based on units sold
Glaukos is registered trademarks

of Glaukos Corporation.
All rights reserved. ©2022
PM-EU-0193

Egs2022 Prog 0606

Uploaded by

Copyright:

Available Formats

Egs2022 Prog 0606

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Egs2022 Prog 0606

Uploaded by

Copyright:

Available Formats

15th EGS Congress

Athens | 4-8 June 2022

The EGS Surgery Day

Saturday, 4 June 2022

Session A - Glaucoma surgery: evidence versus influence?

Session B - Pathways to success

11:20 Moderators: James Kirwan (United Kingdom)

Session C - EGS and Surgical Innovations

13:00 Parallel Industry Sessions

Session D - State of the art and results of various

Saturday, 4 June 2022

Session E - Debate and Q&A (with voting)

16:25 Moderators: Andrew McNaught (United Kingdom)

Siri Mohammed Ezzouhairi

EGS Main Congress

Sunday, 5 June 2022

09:25 The future of EGS: NGP and FEBOS Ingeborg Stalmans

09:35 Gauti Jóhannesson

Coffee break and Poster Session 1 (see page 27)

Session 2 - Take the pulse on…

not EACCME accredited

Session 3 - Can glaucoma be reversed?

not EACCME accredited

Greek Glaucoma Society (GGS) / Associazione Italiana

Sunday, 5 June 2022

Alpine Group - Austrian, Swiss and German

Société Française du Glaucome (SFG)

Asian Pacific Glaucoma Society (APGS)

Middle East Africa Glaucoma Society (MEAGS)

Sunday, 5 June 2022

Turkish Ophthalmological Association (TOS) - Glaucoma

C1.02 - Instructional Course

C1.06 - Instructional Course

C1.05 - Instructional Course

C1.07 - Instructional Course

C1.04 - Instructional Course

Sunday, 5 June 2022

not EACCME accredited

17:55 Parallel Industry Sessions

19:00 Welcome Reception

Session 4 - Precision medicine: going beyond the

Coffee break and Poster Session 2 (see page 32)

Session 5 - Choosing wisely - improving our everyday

Monday, 6 June 2022

not EACCME accredited

12:30 Educational Partner Symposium

C2.04 - Instructional Course

C2.02 - Instructional Course

C2.07 - Instructional Course

C2.06 - Instructional Course

C2.01 - Instructional Course

C2.03 - Instructional Course

C3.01 - Instructional Course

C3.03 - Instructional Course

Monday, 6 June 2022

C3.07 - Instructional Course

C3.05 - Instructional Course

C3.02 - Instructional Course

not EACCME accredited

11:20 Moderators: James Kirwan (United Kingdom)

16:25 Moderators: Andrew McNaught (United Kingdom)

P1.15 Glaucoma: is it though?

P1.16 Developing the intra-ocular pressure metrology in Europe

P1.20 Automatic goniophotography as a learning tool for gonioscopy

P1.29 C atch trials in advanced glaucoma: general glaucoma or macular program

case of idiopathic iridoschisis

P1.50 Structure-function analysis of the peripapillary intrachoroidal cavitation

P2.01 A new paradigm targeting two glaucoma therapy dilemmas

P2.07 T he protective role of fluvoxamine in fibrotic disorders of the eye

P2.09 Incidence and factors associated with brimonidine allergy

P2.14 E ffects of erythropoietin on neuroprotection in an experimental glaucoma model

P2.15 F unctional analysis of glia cells in RGC using coculture system

P2.27 T he effect of metformin on glaucoma lamina cribrosa cells

P2.41 Influence of pharmacological group in adherence to glaucoma medications in a wide population

P2.46 E liciting preferences in glaucoma management - a systematic review of stated-preference studies

P2.60 IOP elevation after intravitreal injections with Ozurdex

P2.61 S econdary glaucoma in patients with familial amyloid polyneuropathy in Cyprus

P2.62 T eaching home tonometry using a remote video link

Moderators: Mario Economou (Switzerland), Stylianos Georgoulas (United Kingdom),

P3.12 S urgical management of primary angle-closure glaucoma

P3.21 T he LiGHT trial 6-year follow-up results

P3.54 C horoidal effusion and hypotony maculopathy after PreserFlo MicroShunt

P3.58 E fficacy of phacoemulsification and phacoemulsification in combination with goniosynechiolysis in the

P3.67 T he management of uveitic glaucoma with PAUL® glaucoma implant

P4.03 L ong-term outcomes of micropulse transscleral cyclophotocoagulation in a tertiary hospital

P4.10 Intermediate-term outcomes of combined phacoemulsification with ab interno excisional goniotomy